Cytokeratins and vimentin in benign lesions and carcinomas of the head and neck by Velden, L. van der
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/145646
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
CYTOKERATINS AND VIMENTIN IN BENIGN LESIONS 
AND CARCINOMAS OF THE HEAD AND NECK 

CYTOKERATINS AND VIMENTIN IN 
BENIGN LESIONS AND CARCINOMAS 
OF THE HEAD AND NECK 
Een wetenschappelijke proeve 
op het gebied van de Medische Wetenschappen 
PROEFSCHRIFT 
ter verkrijging van de graad van doctor 
aan de Katholieke Universtiteit Nijmegen, 
volgens besluit van het College van Decanen 
in het openbaar te verdedigen 
op donderdag 30 september 1999 
des namiddags om 1.30 uur precies 
door 
Lilly-Ann van der Velden 
geboren op 1 9 november 1963 te Rotterdam 
Promotor: Prof. Dr. J.J. Marini Universiteit Maastricht 
Prof. Dr. F.С.S. Ramaekers Universiteit Maastricht 
Co-promotor: Dr. W. Kuijpers 
Manuscriptcommissie: Prof. Dr. P. van den Broek 
Prof. Dr. P. de Mulder 
Prof. Dr. P.J.S. Slootweg Universiteit Utrecht 
Text editing, layout: 
Cover design: 
Printer: 
WordBridge Publishing, Aalten 
Dutch Logo Design, Amsterdam 
Grafia Print & Media Group, Pijnacker 
CIP-GEGEVENS KONINKLIJKE BIBLIOTHEEK, DEN HAAG 
van der Velden, Lilly-Ann 
Cytokeratins and vimentin in benign lesions and carcinomas of the head and neck 
Thesis Nijmegen - with references - with summary in Dutch 
ISBN 90-9012894-8 
Subject headings: oral cavity, larynx, squamous cell carcinoma 
TABLE OF CONTENTS 
Abbreviations 
General Introduction 
Chapter 1 Cytokeratin Expression in Normal and 
(Pre)mahgnant Head and Neck Epithelia an 
Overview 
Chapter 2 Cytokeratin and Vimentin Expression in Normal 
Epithelium and Benign Lesions of the Vocal Cords 
Chapter 3 Cytokeratin and Vimentin Expression in Normal 
Epithelium and Squamous Cell Carcinomas of the 
Larynx 
Chapter 4 Expression of Intermediate Filament Proteins in 
Benign Lesions of the Oral Mucosa 
Chapter 5 Expression of Cytokeratin Subtypes and Vimentin 
in Squamous Cell Carcinoma of the Floor of the 
Mouth and Mobile Tongue 
Chapter 6 Increased Expression of Cytokeratins 8, 18 and 
Vimentin in the Invasion Front of Mucosal 
Squamous Cell Carcinoma 
Summary and Conclusions 
Samenvatting en Conclusies 
Appendices 
Dankwoord 
Curriculum Vitae 
ABBREVIATIONS 
В 
BSCC 
Ck 
FOM 
Gr 
HNSCC 
ISE 
IFP 
KSE 
LPR 
MAb 
N-
N + 
NKSE 
PSE 
RR 
SB 
sec 
Vim 
Ck expression in the basal cell layer 
basaloid squamous cell carcinoma 
cytokeratin 
floor of mouth 
tumor differentiation grade 
head and neck squamous cell carcinomas 
immature stratified epithelium 
intermediate filament protein 
keratinizing stratified epithelium 
lichen planus ruber 
monoclonal antibody 
absence of lymph node metastases in the neck 
presence of lymph node metastases in the neck 
non-keratinzing stratified epithelium 
pseudostratified epithelium 
rete ridges 
Ck expression in the suprabasal cell layer 
squamous cell carcinoma 
vimentin 
GENERAL INTRODUCTION 
The incidence of head and neck squamous cell carcinomas (HNSCCs) accounts for 
about 7% of all malignancies worldwide Approximately 3000 new cases of HNSCCs are 
reported yearly in the Netherlands HNSCCs are clearly associated with several risk 
factors including tobacco, alcohol abuse and chewing of betel nuts The latter is the 
main cause of SCC of the oral cavity, comprising a group with one of the highest 
incidences in South Asia Viral infections can also play a role in the carcinogenesis of 
head and neck tumors Human papilloma virus types 16 and 18 have been suggested 
as playing a potential role in oral and pharyngeal carcinogenesis 2 Epstem-Barr virus was 
also clearly related to the development of nasopharyngeal carcinoma 3 Furthermore, an 
increasing amount of evidence indicates that HNSCC development from exposure to 
carcinogenic compounds depends on the intrinsic cancer susceptibility of individuals 
The treatment of HNSCCs is a ma|or medical management problem It depends on 
the site of and the TNM classification of the lesion and consists of chemotherapy, 
radiotherapy or surgery, separately or in combination So far, chemotherapy treatment 
alone has not been successful in curative treatment of HNSCCs Radiation therapy alone 
has proven an adequate treatment for, in particular, tumors of the larynx (Tl -T3 tumors), 
small tumors of the oropharynx and nasopharyngeal carcinomas Surgical excision, 
especially of larger tumors, may result in restricted speech, swallowing and breathing, 
and an altered cosmetic appearance 
In the last decades external beam radiation and brachytherapy have improved, 
resulting in reduced mortality In cases of advanced head and neck cancer, a 
combination of induction chemotherapy6 followed by radiation therapy has led to a new 
non-surgical strategy for organ preservation and is becoming more and more popular 
as primary treatment789 Furthermore, modified and new anti-cancer therapies, such as 
radiation + platinum technique (RADPLAT)10, immunotherapy" and gene therapy12 are 
being developed 
Despite these new developments, overall survival rates for HNSCC have not 
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improved. 
Most failures of treatment are seen in patients with advanced primary disease. Most 
recurrences are found in the primary region and/or regionally in the neck nodes. Few 
patients with recurrent disease can be saved with secondary treatment. Another cause 
of treatment failure in early-stage HNSCC is the occurrence of second primary tumors 
in the same anatomical area or organ systems, such as the respiratory and upper 
digestive tract.,3,M The development of multi-center tumor foci can be explained by 
cytological changes of the aero- and upper digestive tract mucosa caused by the 
exposition to carcinogens, such as tobacco and alcohol. This phenomenon is called field 
cancerization.15 
It would be of great benefit to have an optimal insight into the biological behavior 
of the tumor, which could potentially help to avoid the choice of a potential unsuccessful 
mutilating treatment. Unfortunately, routine histopathology and the TNM-classification 
are insufficient properly to determine the biological behavior of head and neck tumors. 
These methods do not include other factors, such as perineural growth, intravascular 
growth and extracapsular spread. 
In recent decades molecular markers, detectable by specific antibodies and 
nucleotide probes, have received increasing attention to improve tumor classification and 
tumor differentiation and to obtain a better insight into the biological behavior of cancer. 
Among the differentiation markers much attention has been paid to the intermediate 
filament proteins (IFPs). IFPs are the major components of the mammalian cytoskeleton 
and show a cell-lineage specific expression pattern.16 Cytokeratins (Cks), the epithelial 
specific IFPs, are expressed in patterns that are specific for the individual types of 
epithelial differentiation. Cks are expressed in pairs, consisting of a type I Ck (small, 
acidic, Cks 9-20) and type II Ck (large, neutral to basic, Cks 1-8). In preneoplastic 
lesions and cancers of different organ systems, including HNSCCs, deviating Ck 
expression patterns have been reported.17,18 Although epithelial tissues normally contain 
only Cks, vimentin (the mesenchymal type of IFP) can be coexpressed next to Cks in 
epithelial lesions. It has been suggested that this coexpression of vimentin indicates a 
poor prognosis in epithelial tumors." 
The aim of this study was to improve our insight in to the biological behavior of 
HNSCCs on the basis of their cytokeratins and vimentin expression patterns. Lesions of 
the oral cavity and larynx, the sites with the highest incidence of HNSCCs, were 
examined. The following topics were addressed: 
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characterization of the expression pattern of Cks and of vimentin in the normal 
epithelia of the head and neck region, in clinically benign and malignant lesions 
of the larynx and in oral cavity and lymph node metastases; 
comparison of the Ck profiles and vimentin expression patterns in SCC of the 
larynx and oral cavity; 
correlation of Ck and vimentin profile with pathomorphological findings such 
as grade of differentiation, tumor growth pattern and lymph node metastasis; 
comparison of topographical distribution of specific Cks 8 and 18 and vimentin 
in the invasion front of HNSCCs and SCCs at other anatomical sites. 
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CHAPTER 1 
CYTOKERATIN EXPRESSION IN NORMALAND 
(PRE)MALIGNANT HEAD AND NECK EPITHELIA: 
AN OVERVIEW 
Lilly-Ann van der Velden, H. Ewout Schaafsma, Johannes J. 
Manni, Frans С. S. Ramaekers, Wim Kuijpers 
HEAD & NECK (1993) 15:133-146 
CYTOKERATIN EXPRESSION IN NORMALAND 
(PRE)MALIGNANT HEAD AND NECK EPITHELIA: 
AN OVERVIEW 
ABSTRACT 
Intermediate filament proteins (IFPs) are important markers of tissue differentiation 
and have been receiving increasing interest, in particular, through their applicability 
in the characterization of malignant tumors. Cytokeratins (Cks) are a family of IFPs 
that are typically specific for epithelial cells. They are expressed in certain combina-
tions depending on the type of epithelium and the degree of differentiation. This 
review presents a critical analysis of the available data on Ck expression in normal 
and (pre) neoplastic epithelia of the head and neck region. Special attention is paid 
to technical and cell biologic pitfalls, which can lead to false-negative or false-posit-
ive data. It appears that only a limited fraction of the reported data contributes 
substantially to our knowledge of IFP expression in head and neck cancer because 
of the use of ill-defined, often formalin-fixed and paraffin-embedded, tissue 
specimens, and the application of limited panels of monoclonal antibodies. It is 
concluded that the use of immunocytohistochemistry is promising for the differential 
diagnosis of head and neck tumors and contributes to our knowledge on their 
biologic behavior. However, documentations of more complete Ck expression 
patterns of normal and (pre)malignant epithelium are required, together with their 
correlation to clinical parameters. 
INTRODUCTION 
For the management of cancer patients, there is a great demand for new diagnostic 
tools to improve the characterization of malignancies. New reagents, such as 
monoclonal antibodies or nucleic acid probes, are being developed forthis purpose. The 
ultimate goals to be reached with such reagents include: (1) improving of tumor 
classification on the basis of the histopathologic diagnosis and the further differentiation 
of apparently identical tumors; (2) gaining more insight into the biologic behavior of a 
tumor in the individual patient; (3) improving methods to diagnose tumor tissue in fine-
needle aspiration biopsy smears or other cytological preparations; and (4) detecting 
small neoplasias or microscopic metastases at an early stage. 
In an attempt to better correlate the prognosis with the histopathology, extensive 
scoring methods have been introduced to increase the objectivity of tumor grading and 
to clarify the classification system.1"6 However, none of these methods has been found 
to have a better predictive value than the TNM classification. 
In addition, more sophisticated techniques, such as immunohistochemistryfor a large 
variety of cell markers, flow cytometry, and DNA in situ hybridization, have been applied 
for the further characterization of tumor cells. Of all the markers used, intermediate 
filament proteins (IFPs), which form a major part of the cytoskeleton in eukaryotic cells, 
have been receiving increasing interest during recent years.7 In this review, a critical 
analysis is presented of the data reported in the literature with respect to the expression 
patterns of IFPs in normal and (pre)neo-plastic epithelia of the head and neck region. 
Special attention is paid to the cytokeratins (Cks), a family of IFPs specifically expressed 
in epithelial. Furthermore, the potential use of antibodies to IFPs as a new diagnostic tool 
is discussed. 
INTERMEDIATE FILAMENT PROTEINS 
Intermediate-sized filaments are major components of the mammalian cytoskeleton. 
Their proteinaceous constituents can be subdivided into six groups, each of which is 
relatively specific for certain tissues or cell types. The function of IFPs is still largely 
unknown, but it seems likely that they make a contribution to the physical strength and 
signal transduction in the cell.8,9 The largest subgroup of IFPs is formed by the Cks, which 
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are generally specific for epithelia. They can be subdivided into type I (40-64 kDa 
molecular weight; acidic, including Ck nos. 9-20) and type II (52-68 kDa molecular 
weight; basic to neutral, including Ck nos. l-8).10,n Type III intermediate filaments'2 
consist of vimentin which is specific for mesenchymal cells, desmin which is specific for 
muscle tissue, glial fibrillary acidic protein (GFAP) which is expressed in glial cells and 
astrocytes, and peripherin13 which is specific for neuronal cells. Type IV are the 
neurofilament proteins expressed in nerve cells, type Vthe nuclear A- and B-type lamin 
proteins which constitute the nuclear lamina, and type VI IFPs comprise nestin, which is 
specific for central nervous system stem cells.'4 
The particular type of IFP present has been used to help promote cell differentiation. 
Coexpression of more than one type of IFP has been reported in normal adult and 
embryonal tissues and in tumors; in such cases, vimentin is the most commonly 
coexpressed IFP. Cks are coexpressed with vimentin in certain malignant epithelial and 
nonepithelial (mostly malignant) tumors, such as carcinomas of the head and neck,'5,16 
thyroid,'7 lung,'8 kidney," etc. Mesotheliomas,20 malignant lymphomas, melanomas, 
and spindle cell carcinomas2' may also coexpress Cks and vimentin. Normal epithelia, 
such as the nasal mucosa and enamel organ, occasionally show the coexpression of Cks 
and vimentin.22,23 
CYTOKERATINS 
Types I and II, which make up the main class of IFPs in epithelial tissues, assemble 
into heteropolymers which require at least one type I (acidic) and one type II (basic) 
polypeptide.9,24"27 During development, the epithelial cells express a set of typical Cks for 
a particular program of differentiation.28 Cks are distributed in specific combinations 
depending on the type of epithelium in which they are expressed.'°'29 
For example, stratified epithelia express Cks 5 and 14 in their basal cell layer. ' In 
non-keratinizing stratified squamous epithelia (NKSE) Cks 4 and 13 are expressed in the 
supra basal cell layers,32"34 whereas cornified epithelia show the specific expression of Cks 
1,2, 10, and 11. Corneal epithelium shows the exclusive expression of Cks 3 and 12.35 
Hyperproliferative epithelia and oral epithelia with a high cell turnover express Cks 
6 and 16,36 although recent reports have indicated that these are more typical for the 
squamous type of differentiation.37 Simple epithelial cells (with a free luminal surface and 
contact with the basal lamina) express Cks 8 and 18 and, in most instances, also Cks 
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738'39 and 19.40 Mixed epithelia express Cks 5, 14, and 1741,42 in their basal cell layers, 
and Cks 8 and 18 in their luminal cells. Transitional epithelia of the urogenital tract 
express Cks 7, 8, 13, 18, 19, and 20.43,44 
In addition to these basic rules, Ck expression in a certain type of epithelium has 
been found to depend on various factors, such as the stage of embryonal 
development,45,46 inflammation,47"49 and environmental influences, such as vitamin A,50,51 
growth conditions,52"55 and (pre) malignant transformation.56 
DETECTION METHODS 
IFPs can be analyzed by one- and two-dimensional gel electrophoretic techniques 
combined with ¡mmunoblotting and appropriate (monoclonal) antibodies. This procedure 
allows the complete separation of all 20 human Cks on the basis of their molecular 
weight and isoelectric pH, but can also serve to identify and quantitate any 
posttranslational modifications.10,52 However, a major drawback of this procedure is the 
difficulty in correlating the Ck profile to a specific cell type when dealing with a 
heterogeneous cell population, because in principle, the method uses whole tissue 
extracts. Furthermore, low levels of Ck expression often cannot be detected by this 
laborious procedure. 
Immunohistochemical procedures using specific monoclonal antibodies are more 
sensitive, as they allow the determination of the Ck expression patterns of individual cells 
in complex epithelia. 
The first antibodies to be produced against IFPs were polyclonal antisera. These 
reagents recognize many epitopes (antigenic determinants) shared by different Ck 
polypeptides. More specific recognition of individual Cks can be achieved using 
monoclonal antibodies (MAbs). 
Depending on the purpose of the examination, it is mandatory to choose between 
broad-range antibodies, which recognize epitopes common to many Cks, or narrow-
range antibodies, which recognize one epitope that may not be shared among the Cks 
and may only be present in a single Ck polypeptide or Ck protein configuration. 
To obtain optimal results and to avoid false-negative or false-positive data, it should 
be realized that IFP configuration and detectability can be strongly influenced by 
decalcification,57 fixation,58,59 and the embedding procedures used in routine histology. 
These procedures can easily change the epitopes, making them inaccessible to 
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Figure 1. Immunohistochemical staining of normal pseudostratified (A,B) and stratified epithelium (C,D) of the 
larynx with monoclonal antibodies (MAb) directed against different cytokeratin polypeptides. A MAb RCK 106 
(Ck 18). BMAbAE 14 (Ck 5). С MAb 6B10 (Ck 4). DMAbAE 14 (Ck 5). 
antibodies. For example, formalin fixation and subsequent paraffin embedding have 
been shown to diminish the ¡mmunocytochemical detectability of keratin and vimentin.,6 
These problems have been overcome by using frozen sections prepared from fresh 
tissues. During recent years, an increasing number of MAbs have become available 
which can be used in routinely prepared, formalin-fixed tissue samples embedded in 
pa raff i η.12'''0'60 Examples of Ck staining with MAbs, which specifically stain basal cells 
and supra-basal cells in pseudostratified and stratified epithelium of the larynx, are 
shown in Fig. 1. 
THE APPLICATION OF INTERMEDIATE FILAMENT PROTEINS AS MARKERS FOR THE 
DIFFERENTIAL DIAGNOSIS OF HEAD AND NECK TUMORS 
The use of antibodies to IFPs, in particular Cks and vimentin, has been found to 
greatly assist in the identification of tumors which cannot be accurately identified using 
routine histopathologic procedures.7 These reagents have shown their value in solving 
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differential diagnostic problems, such as differentiating between anaplastic nasopharynx 
carcinomas and sarcomas or non-Hodgkin lymphomas in the nasopharynx and/or 
neck 6' iA Distinguishing between true sarcomas (which predominantly express vimentin) 
and spindle cell carcinomas or carcinosarcomas (which express Cks and vimentin) is 
possible using MAbs 65 6 8 The differential diagnosis of salivary gland tumors, metastatic 
carcinomas,6 71 and neural tumors, can be achieved with antibodies against Cks, 
vimentm, neurofilaments, and GFAP 
Antibodies directed against Cks can also assist in providing a diagnosis in small 
amounts of tissue 72 74 MAbs against Cks are also useful for helping to resolve the 
problem of differentiating between reactive mesenchymal cells and individual tumor cells 
in postradiotherapy tissue 75 Light microscopic examination of small amounts of tissue 
obtained by various diagnostic procedures, such as fine-needle aspiration and bronchial 
brushings, is not always diagnosticai / conclusive MAbs against Cks can refine the 
diagnosis in such cases 7 6 7 7 Besides these applications in oncology, IFPs have shown 
their value for studying benign lesions, such as psoriasis7879 and cholesteatomas 4 7 4 9 
Furthermore, the tissue specificity of IFPs can be employed for the characterization of 
unindentified cells and to observe functional changes in developing and adult tissues 
Finally, IFPs can enhance the specificity of other techniques, such as flow cytometry and 
in situ hybridization 8 2 8 Э 
CK EXPRESSION IN HEAD AND NECK TISSUES 
Epithelia 
During embryologie development, the epithelial lining of the head and neck region 
originates from the embryonic endoderm and ectoderm, which gives rise to a large 
variety of epithelia in the adult, including cormfying, non-cornifymg, simple, and 
pseudostratified epithelia The data reported on Ck expression in various head and neck 
epithelia are summarized in Tables 1A and IB Only the studies that used either two-
dimensional gel electrophoresis or well-defined, polypeptide-specific monoclonal Ck 
antibodies in immunohistochemical or Western blotting studies were used for the 
compilation of these tables Without trying to be comprehensive, the expression patterns 
of Cks in head and neck tissues can be summarized as follows below 
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Masticatory mucosa or keratinizing stratified epithelium (KSE) covers the hard palate, 
the attached gingiva (alveolar mucosa), and the papillae of the tongue 4 5 The Ck 
profile of these epithelia show that cormfication Cks 1 ,2 , 10, and 1 1, as well as 
hyperproliferation Cks 6 and 16 are expressed in the suprabasal layers of this type of 
epithelium, whereas Cks 5 , 1 4 , 1 5 , and 1 7 are present in the basal tissue layers 
NKSE lining the oropharynx, nonattached gingiva (sulcular mucosa), the tongue, 
lingual epiglottis, vocal cords, surface palatine tonsil, and esophagus, generally lack 
cormfication markers and show consistent expression of the stratification-related Cks 4 
and 13 in addition to basal cell Cks 5, 14, 15, and 17 Simple epithelial markers, such 
as Cks 7, 8, 18, and 19, are expressed inconsistently in basal cell layers, whereas 
hyperproliferation Cks 6 and 16 are found irregularly in the suprabasal cell layers 
The posterior nasal cavity, paranasal sinuses, laryngeal ventricle, and bronchial 
epithelium are lined with respiratory or pseudostratified columnar epithelium (PSE), 
whereas a combination of respiratory and non-keratinizing stratified epithelium covers 
the nasopharynx and laryngeal epiglottis86 89 In these tissues, simple cell Cks 7, 8, 18, 
and 19 and basal cell Cks 5, 14, 15, and 17 are expressed, but the expression of the 
stratification markers, such as Cks 4 and 13, is only observed occasionally 
The simple cell Cks 8 and 18 are expressed m the neuroendocrine Merkel cells, 
mostly located in the basal layers of the deep rete ridges of the epithelium48 B8 
Junctional epithelium, which forms the attachment site between the non-keratinizing 
gingival epithelium and the tooth enamel, is a non-keratinizing stratified epithelium with 
a decreasing number of cell layers towards the enamel, it expresses Cks 4, 13, and 
i ç 48 87 88 90 | n gddition, expression of Cks 5 and 14, as well as a heterogeneous 
expression of Cks 6 and 16, has been described by Morgan et a l 8 7 8 8 
Salivary Glands 
Salivary glands can be divided into the ma|or (parotid, submandibular, and sub-
lingual) and minor salivary glands These glands contain several epithelial structures, 
including the secretory unit which consists of mucus- or serous-secreting acinar cells, 
surrounded by myoepithelium or basal cells The intercalated and striated ducts consist 
of single-layered simple epithelium, and the excretory ducts consist of pseudostratified 
or stratified cuboidal epithelium 
Cks 5, 14, and 1 7 are expressed in the basal cells of the ducts and in the 
myoepithelium of acini3091 Ck 18 is expressed in the columnar and cuboidal luminal 
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cells 929A Draeger et al94 and Troyanovsky et a l 9 5 described the expression of Ck 8 in 
the same areas, whereas the former authors observed the heterogeneous expression of 
Ck 13 in the large luminal cells Ck 19 was found in the ductal system 93 96 '7 
Enamel Organ 
Kasper et a l 2 2 described the Ck pattern of the human fetal and adult enamel organ 
They observed the expression of the basal cell markers, Cks 5, 14, and 1 7, and of the 
simple cell markers, Cks 7, 8, and 19, Ck 18 was only expressed in trace amounts 
CYTOKERATIN EXPRESSION IN PRENEOPLASTIC LESIONS AND TUMORS 
OF THE HEAD AND NECK REGION 
Generally, the cell type-specific pattern of IFP expression of various tumors is 
maintained during malignant growth and metastasis, although exceptions have been 
identified Depending on the degree of differentiation, tumor cells may either express 
new subsets of IFPs (in particular, vimentin and Ck subsets) or even lose the expression 
of the original IFPs98 For example, in lung cancer, Ck 13 is down-regulated as a result 
of the "dedifferentiation" of squamous cell carcinoma (SCC), whereas Ck 18 is 
expressed increasingly upon malignant progression " Van Eyken et al '00 showed the 
unexpected appearance of Ck 7 in hepatoblastoma 
Most malignancies in the head and neck area are SCCs derived from the epithelia 
which line the oral, nasopharyngeal, pharyngeal, or laryngeal cavities Only scarce data 
are available on IFPs and Ck expression patterns in preneoplastic lesions and tumors of 
these head and neck epithelia The results of recent studies are summarized in Table 2 
Preneoplastic Lesions of the Head and Neck 
The available data on preneoplastic lesions in oral epithelia suggest that Ck 19 
expression in non-keratmized oral epithelium increases with progression of the grade of 
dysplasia If hyperkeratosis is present in these lesions, Ck 19 expression is nearly always 
absent Dysplastic lesions of keratinized oral epithelia shows a patchy suprabasal Ck 19 
expression, whereas this Ck type is normally found in the basal cell layers Furthermore, 
carcinoma in situ of oral epithelia shows a patchy distribution of Ck 19 1510' Lindberg 
and Rheinwald'01 concluded that Ck 19 expression appears to increase during malignant 
transformation of oral epithelia Murakami et al ,02 described the expression of Ck 13 
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and an increased expression of Ck 19 in simple hyperplasia of the pynform sinus 
According to these authors, the expression of Ck 19 increased and the expression of Ck 
13 decreased with increasing grades of dysplasia As a result, Ck 13 expression was 
absent, in carcinoma-in-situ, whereas Ck 19 expression was abundant 
Squamous Cell Carcinomas 
SCCs of the oral cavity normally express Cks 4, 5, 13, and 14, which are typical of 
the epithelia in this region However, the data collected on SCCs from various epithelia 
of the head and neck area revealed an increased expression of simple cell markers (ie, 
Cks 18 and 19) with increasing tumor grade 1 0 , 6 8 B , 0 ' ш з , 0 5 Morgan et a l β β showed a 
decreased expression of cormfication markers (Cks 1,10, and 11) and stratification 
markers (Cks 4 and 13) during malignant progression and increase of the tumor grade 
A comprehensive study by Murakami et a l 1 0 2 on the Ck profile of tumors from the 
pynform sinus showed a decrease in Ck 4 and an increase in Ck 19 expression, 
correlating to the progression of malignancy Moll et al 10 and Wild et al reported Ck 
expression of the basal cell markers and supposed hyperproliferation markers in various 
head and neck SCCs 
Salivary Gland Tumors 
Adenocarcinomas in the head and neck region are mostly derived from the ducts of 
the ma|or and minor salivary glands For the diagnosis of salivary gland tumors, IFP 
staining is mainly used for determinating the epithelial nature of the spindle-shaped cells 
in the tumors 
Data on IFP coexpression in salivary gland tumors have been described by several 
authors ' 7 '°6 "° Two-, three-, and even fourfold coexpression of IFP, such as Ck, 
vimentin, glial fibrillary acidic protein, and desmin, have been observed in the normal 
tissue and tumors of the salivary glands ш The complexity of the IFP composition of 
these tissues and their tumors is also evident from the Ck staining patterns Caselitz et 
a l 9 2 demonstrated Ck 18 expression in pleomorphic adenoma, adenoid cystic 
carcinoma, and Wharthm's tumor Draeger et a l 9 A demonstrated the expression of Cks 
7, 8, 14, 18, and 19 in the tubular and in the most unstructured solid and trabecular 
parts of pleomorphic adenomas Cks 1, 2, 10, 13, and 14 are expressed in the 
epidermoid, partially keratinizing portions 
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Odontogenic Tumors 
The histogenesis of several odontogenic tumors has been a sub|ect of considerable 
controversy IFPs, predominantly Cks and vimentin, have been used to clarify the 
histogenesis and to gain more understanding of several odontogenic tumors, including 
calcifying epithelial odontogenic tumor,n2calcifying odontogenic cyst,"3114 granularceli 
ameloblastoma,"5 " 7 and congenital gingival granular cell tumor " 5 
However, at present only a limited number of tumors have been studied with a small 
panel of monoclonal antibodies Therefore, no decision can be made on the usefulness 
of IFPs in the diagnosis of odontogenic tumors 
Intermediate Filament Expression In Head and Neck Cancer Cell Lines 
SCC lines form useful models to observe the invasive potential and the therapeutic 
importance of chemotherapy and radiotherapy 
Four SCC lines originating from tongue, larynx, and buccal carcinomas cultured in 
vitro were investigated by Rupniak et al " B Two of these cell lines expressed typical Ck 
markers for keratinizing basal cells and hyperproliferative epithelium (ie, Cks 5, 6, 14, 
and 16) The other two contained Cks typical for simple epithelia (ie, Cks 8, 18, and/or 
19) These data show that cell lines derived from SCCs of the oral cavity only partly 
retain the cytokeratin characteristics of the original neoplasms Crooi|mans et a l " 9 
investigated two cell lines derived from a well-differentiated SCC from the floor of mouth, 
and from a moderately to well-differentiated SCC of the epiglottis, growing as xenografts 
in nude mice Both expressed Cks 5, 7, 8, 10, 14, 18, and 19 One of the cell lines also 
expressed Cks 4 and 13 Vimentin expression was observed in the other cell line Both 
cell lines expressed a mixture of Cks typical for squamous and simple epithelia 
DISCUSSION 
Monoclonal and polyclonal antibodies directed against IFP can be of great assistance 
in the characterization of tissue type differentiation Therefore, they can be applied in the 
differential diagnosis of undifferentiated and anaplastic carcinomas, spindle cell tumors, 
micrometastases, and cells in fine-needle aspirations Independent of the anatomic site, 
the Ck profiles correlate well with the histologic appearance and the degree of 
differentiation of the epithelium, even in carcinomas The main purpose of this review 
was to provide a critical analysis of the literature on IFPs, in particular Ck expression 
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patterns ¡η head and neck epithelia and their application as markers for the diagnosis 
of (pre)malignant lesions. 
Although several studies have been performed on this topic, only a fraction of the 
reported data add substantially to our knowledge of IFP expression in head and neck 
cancer. This is mainly due to the use of heterogeneous tissue specimens and the fact that 
only small panels of antibodies were applied. In addition, some of the applied methods 
were open to error. For example, if fixed tissues are used, possible fixation-induced 
alterations in the epitopes cannot be excluded. 
When using MAbs it should be kept in mind that epitope masking is a common 
phenomenon. Examples of false-negative results, arising from epitope masking, have 
recently been described44''20 and may be overcome by staining with more than one MAb 
against a single keratin. Furthermore, sometimes no mention was made of the treatment 
protocols, such as radiotherapy or chemotherapy, and control specimens were frequently 
lacking. This might explain the great variation between some of the data reported by 
Murakami et al.1 0 2 and the other data shown in Table 2. 
On the basis of the studies described above, the Ck expression pattern of the normal 
epithelial lining of the head and neck tract can be summarized as follows below (for 
references see "Epithelia"): 
Keratinizing stratified epithelia of the attached gingiva and hard palate express 
cornification markers, stratification markers, basal cell markers, and (presumed) 
hyperproliferation markers. 
Non-keratinizing stratified epithelia of the oral cavity, pharynx, and larynx express 
stratification markers, basal cell markers, and hyperproliferation markers. In general, the 
normal stratified epithelia in the head and neck region are not hyperproliferative. 
Therefore, it is rather surprising that some of them express Cks 6 and 16, which have 
been described in the epidermis as hyperproliferation markers. There may be a 
correlation with their high turnover rate, although Wetzels et al.3 7 have recently shown 
that these Ck subtypes may show a strong correlation with squamous differentiation in 
malignancies. 
Pseudostratified epithelia of the epiglottis, nasopharynx, and larynx express a Ck 
profile which reflects a combination of the profiles of stratified and simple epithelium. 
From the small number of (pre)malignant lesions tested with a broad panel of 
antibodies, several trends can be observed. 
When dividing Ck into the differentiation marker groups as described above, the Ck 
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profiles of (pre)neoplastic squamous lesions and tumors generally suggest that 
1. The expression of cornification or terminal differentiation markers decreases during 
malignant progression, invasion, and metastasis. The correlation with histologic (pre) 
cornification of the malignant epithelial cells, however, continues to exist.16,88,102 
2. The expression of stratification markers, especially Ck 13, in nonglandular epithelium 
decreases drastically during carcinogenesis and seems to correlate with the degree 
of differentiation of the preneoplastic lesion or carcinoma.10'88,102,105 
3. The "simple epithelial cell" markers are not specific for one-layered cubic epithelia. 
They are also expressed during early embryonic development and in undifferentiated 
tissues. This expression can be seen in dysplasia and SCCs and is correlated with an 
increase in tumor grade.16,29,88'101"105 
The trend of altered Ck expression during malignant progression is apparently 
independent of the site of the lesion in the head and neck region. These trends confirm 
comparable observations in epithelia at other sites of the body; the epithelia of the 
esophagus, skin, respiratory system, and urogenital tract show similar phenomena. A 
decrease in Ck 13 expression can be observed during malignant progression and 
transformation in skin34 and of Ck 10 in the esophagus.121 In transitional cell 
carcinomas,43,120,122 SCCs of the lung,99,123,124 (pre)malignant, and SCCs of the female 
genital tract,54,125 an increase in Ck 18 expression has been observed with tumor 
progression. These results are, however, slightly dependent on the MAb used. 
Many questions still remain to be answered concerning the biologic background of 
Ck expression patterns in normal and malignant head and neck epithelia and possible 
relations with the biologic growth rate, metastatic potential, and response to different 
types of therapy. For example, as glandular cell type Ck markers are normally expressed 
in cuboidal and columnar epithelium and adenocarcinomas, it would be of importance 
to know whether SCCs, which express these "simple epithelial" markers, also show 
features of adenocarcinomas, comparable with those observed in lung SCCs.99 Another 
question that remains unanswered is whether or not increased Ck 19 expression is one 
of the early signs of malignant transformation. 
A decrease in Ck 13 expression also correlates with an increasing degree of 
malignancy in several types of cancer. We wonder whether this change can be 
considered to be a sign of progression or malignant transformation. 
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Although Ck expression patterns are mainly related to light-microscopic observations 
and not to clinical parameters, Ivanyi et al60 recently correlated Ck 10 expression to the 
tumor stage of vulvar carcinomas. In tumors of the breast, a correlation has been 
observed between vimentin expression and poor prognosis.12A'127 For the head and neck 
region such studies are not yet available, but future studies are expected to have clinical 
implications for the individual patient. 
CONCLUSIONS 
The use of IFP expression seems promising for making pathologic differential 
diagnoses of head and neck tumors, although there are still several technical and cell 
biologic pitfalls. Characterization of the Ck pattern of tumors is expected to increase our 
knowledge of the biologic behavior of tumors and the prognosis. Documentation of 
more complete Ck patterns in head and neck epithelia, premalignant lesions, and 
tumors are required together with correlations with clinical parameters. Further research 
will help to prove the true benefits of Ck characterization. 
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CYTOKERATIN AND VIMENTIN EXPRESSION IN NORMAL 
EPITHELIUM AND BENIGN LESIONS OF THE VOCAL CORDS 
ABSTRACT 
The expression of cytokeratins and vimentin was studied immunohistochemically in 
normal epithelium and 1 2 benign lesions of the vocal cord with the use of a broad 
panel of monoclonal antibodies against cytokeratins and vimentin Histology 
showed that the various lesions contained hyperkeratotic, hyperplastic and atrophic 
epithelium, irrespective of their clinical appearance Especially the Ck profile of the 
(hyper)keratotic lesions was changed in comparison with the native epithelium 
Increased expression of the keratmization marker Ck 10 was associated with 
decreased expression of the stratification markers Cks 4 and 13 Expression of the 
basal cell markers Cks 14 and 17 and hyperproliferation-associated Ck 16 was 
increased in all the benign lesions, except in atrophic epithelium These expression 
patterns differ from those observed in malignant epithelial lesions The latter show 
a marked expression of simple cell Cks and vimentin and more pronounced 
expression of hyperproliferation-associated markers than the benign lesions 
INTRODUCTION 
Epithelial lesions of the larynx can be benign or malignant Most of the benign lesions 
are pseudotumours, such as vocal cord nodules, hyperkeratotic lesions and polyps It 
is often difficult to make a clinical diagnosis and to distinguish between benign, 
premalignant and malignant epithelial lesions of the vocal cords2 
In the past decade, the expression of intermediate filament proteins (IFPs) has been 
used to further characterize various types of malignancy IFPs are a ma|or component 
of the cytoskeleton and are expressed in a tissue-specific fashion Various cytokeratins 
(Cks) are specific for epithelial cells and have proven to be important markers for the 
study of normal and abnormal epithelial differentiation 3 In man these Cks comprise a 
family of 20 different subtypes which are expressed in relation to the type of epithelial 
differentiation In addition, the expression of vimentin, the mesenchymal type of IFP, was 
studied, because several investigators have established that it exists in epithelial cells and 
carcinomas 4 
Ck expression may change during hyperplasia, hyperkeratosis and malignant 
transformation 5 For example, in squamous cell carcinomas (SCCs) of the head und 
neck, shifts have been observed in the Ck expression patterns as compared with the 
normal epithelium and amongst the different tumor grades6 Although several studies 
have dealt with Ck expression in benign epithelial lesions of the oral cavity/ ~9 to our 
knowledge, only one study has been published focusing on the larynx , 0 These authors 
investigated the Ck expression in vocal cord polyps using broadly cross-reacting 
antibodies and reported significant heterogeneity in the Ck subtypes present in the 
different polyps In the present study, IFP expression was investigated in normal 
epithelium and 12 histopathologically different benign epithelial lesions of the vocal 
cords using a large panel of monospecific antibodies directed against the representatives 
of the various Ck subsets, as well as a vimentin antibody 
MATERIAL AND METHODS 
Tissues 
Normal vocal cord epithelium was obtained within ten hours of death from seven 
autopsy cases without any history of laryngeal disease Fresh tissue samples were 
obtained from clinically benign lesions during microlaryngeal surgery Immediately 
after dissection, the specimens were frozen in liquid nitrogen and 5 μιη thick 
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cryosections were made To establish the histological diagnosis the epithelial lesions 
were evaluated according to the classification of Fitz-Hugh et al " and Loire et al ,2 
by two different observers In the case of discrepancy, consensus was reached by pint 
re-evaluation After it had been established histologically that the 12 lesions were 
benign, additional sections were processed for immunohistochemistry 
Immunohistochemistry 
Immunohistochemistry was performed according to the indirect immunoperoxidase 
technique as reported previously '3 The staining patterns were recorded semi-
quantitatively Positive staining of 75% of the target cells was defined as homogeneous 
staining pattern Positive staining of 25 - 75% of the target cells was defined as 
heterogeneous staining Staining of fewer target cells was defined as sparse or scattered 
staining pattern. 
Antibodies 
Twenty-one different mouse monoclonal antibodies (MAbs) directed against 
individual Cks and one monoclonal antibody to vimentin were applied in this study The 
following monoclonal antibodies were used RKSE60 (Ck 10), 6B10 (Ck 4), 2D7 and 
1C3 (Ck 13), AE14 (Ck 5), RCK 107, LL001 and LL002 (Ck 14), KA12 (Ck 6), LL025 
(Ck 16), E3 (Ck 17), RCK 105 and OVTL12/30 (Ck 7), CAM 5 2 and M20 (Ck 8), 2C8, 
RGE53, CK18 2 and RCK 106 (Ck 18), LP2K and RCK 108 (Ck 19) and RV202 
(vimentin) For source and further specifications of these antibodies see reference 14 
RESULTS 
In all the specimens, the normal epithelium of the vocal cords of the autopsy cases 
consisted of non-keratimzing squamous epithelium (NKSE), while the ventricle was lined 
with immature squamous epithelium and pseudostratified epithelium The subglottic 
region was also lined with pseudostratified epithelium 
The 12 benign lesions comprised four nodules, three polyps, one squamous 
papilloma, two lesions with hyperkeratosis and two lesions which showed non-specific 
chronic inflammation The histological features of the lesions varied widely between the 
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Figure 1. Ck expression in NKSE of the normal vocal cords. The arabic numerals refer to the different Ck 
subtypes. Bar indicates 100 μηη. Note the different expression patterns of Ck 19 in the NKSE adjacent to 
immature stratified epithelium (F) and in the NKSE (G). 
different specimens and also within the same specimen. They comprised 
(hyper)keratinization, atrophy and hyperplasia, while atypia was observed incidentally. 
Epithelial hyperplasia was mainly observed in the laryngeal polyps and papillomatosis 
and in the two lesions with non-specific inflammation. Atrophic epithelium was observed 
in the laryngeal nodules. The hyperkeratotic lesions mainly showed parakeratosis and 
orthokeratosis, while the squamous papi l loma, the laryngeal polyps and the nodules 
showed sparse cornif ication. 
A localized distention of the tissue between the lamina propria and the epithelium 
referred to as "blistering" was observed in 3 of the lesions (one polyp, one hyperkeratotic 
lesion and one lesion with non-specific inflammation), while 2 of them (the polyp and the 
lesion with non-specific inflammation) showed extensive subepithelial accumulation of 
lymphocytes. 
None of the patients developed an laryngeal squamous cell carcinoma througout a 
follow up period of 5 years. 
The Ck profile is described according to their reactivity pattern of the different types 
of epithelial differentiation present in the various specimens. The results are depicted in 
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Figure 2. Ck expression patterns in hyperkeratotic lesions of the vocal cord. The arabic numerals refer to the 
different Ck subtypes. Bar indicates ΙΟΟμη-ι. 
Figs. 1-5. 
Cornification marker - Ck 10 
In epithelium of the vocal cord, only scattered suprabasal cells reacted with the Ck 
10 antibody (Fig. 1 A). In the lesions with keratinization there was an abundant expression 
of Ck 10 in the suprabasal cell layers (Fig. 2A). The expression of Ck 10 in hyperplastic 
epithelium was sparse (Fig. ЗА). In the lesions with laminar desquamation and in 
atrophic epithelium, Ck 10 expression was only apparent when there was 
(pre)keratinization (Fig. 4A). 
Stratification markers - Cks 4 and 73 
In the normal epithelium, Cks 4 and 13 showed homogeneous expression in the 
suprabasal cell layers and a scattered expression in the basal and parabasal cell layers 
(Fig. IB). 
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Figure 3. Ck expression patterns in hyperplastic epithelium of benign lesions of the vocal cord. The arabic 
numerals refer to different Ck subtypes. Note the expression of Ck 7 in the uppermost cell layer of a lesion with 
hyperplastic epithelium, lying adjacent to immature squamous epithelium (G). 
Bar indicates 100 μπι. 
In all the lesions, Cks 4 and 13 were expressed suprabasally, but this pattern differed 
in relation to the epithelial phenotype. In the hyperkeratotic lesions, the expression of Cks 
4 and 13 was sparse to heterogeneous (Fig. 2B). In areas of hyperplasia, the 
stratification markers were heterogeneously expressed in the suprabasal cell layers (Fig. 
3B). The atrophic epithelium showed homogeneous suprabasal expression, with 
exception of the parabasal cell layer (Fig. 4B). In the areas of blistering expression of Cks 
4 and 13 was greatly decreased (Fig. 5A). 
Basa/ cell markers - Cks 5,14 and 17 
In the normal epithelium, Cks 5 and 1 4 were expressed homogeneously in the basal 
and parabasal cell layers (Fig. 1С). Ck 17 was heterogeneous expressed in the 
(para)basal cells (Fig. IE). 
In the basal and parabasal cell layers of the benign lesions the expression of Ck 5 
was generally sparse. Irrespective of their type of differentiation, most of the lesions 
showed homogeneous expression of Ck 14 in all the cell layers (Figs. 2C and 3C). In the 
atrophic epithelium, Cks 1 4 and 1 7 expression was limited to the basal cell layers and 
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Figure 4. Ck expression patterns in atrophic epithelium of benign lesions of the vocal cord. The arabic 
numerals refer to the different Ck subtypes. Bar indicates 50 μ. 
Ck 14 was also parabasally expressed (Figs. 4 C and 4E). Keratotic lesions and 
hyperplasia showed heterogeneous expression of С к 17 in all the suprabasal cell layers 
(Figs. 2E and 3E). 
Hyperproliferation-associated markers - Ocs 6 and 16 
The normal epithelium of the vocal cords showed homogeneous expression of Ck 6 
in the suprabasal cell layers, whereas the basal cell layer showed a heterogeneous 
expression. Ck 16 was expressed in scattered areas of suprabasal cells (Fig. 1 D). 
In all the lesions Ck 6 was expressed homogeneously. Keratotic lesions and 
hyperplasia showed heterogeneous expression of Cks 16 in all cell layers. In atrophic 
lesions, Ck 16 expression was limited to the suprabasal cell layers in areas with 
keratinization (Fig. 4D). 
Simple epithelium-related markers - Cks 7, 8, 18 and 19 
Cks 7, 8 and 18 were not expressed in NKSE of the vocal cords. Ck 19 was 
expressed heterogeneously in the basal cells and focally in the suprabasal cells. The 
epithelium of the vocal cord adjacent to the ventricle and subglottic region expressed 
Cks 7, 8 and 18 in the uppermost cell layers, while Ck 19 was expressed 
heterogeneously in all cell layers in these areas (Fig. 1 F). This expression profile was also 
found in the epithelial lesions bordering the ventricle and subglottic region (Fig. 3G). 
Benign Lesions of the Vocal Cords 37 
Figure 5. Expression of Ck 4 (A), Ck 18 (B) and vimentin (С) in an area of blistering in a lesion with 
hyperplastic epithelium. Expression of Ck 4 is decreased in the area above the blister, while Ck 18 and 
vimentin are exclusively present in the basal cells lining the blister. Bar indicates ΙΟΟμηη. 
Generally, Cks 7, 8 and 1 8 were not expressed in the lesions, except in the lesions 
with subepithelial blistering, which showed heterogeneous expression of Cks 8 and 18 
in the basal cell layers (Fig. 5B). 
Expression of Ck 19 was limited to the hyperplastic and atrophic epithelium. The 
hyperplastic epithelium showed heterogeneous expression of Ck 19 in all the cell layers, 
but expression could differ widely at the various sites (Fig. 3F). In atrophic epithelium, Ck 
1 9 was expressed heterogeneously in the basal cells and scattered in the suprabasal cell 
layers (Fig. 4F). In the hyperkeratotic lesions, there was little or no expression of Ck 19 
(Fig. 2F). 
Mesenchymal specific cytoskeletal protein- vimentin 
Vimentin expression in normal vocal cord epithelium was limited to mesenchymal 
cells of the connective tissue. This also applied to the lesions. The lesions with 
subepithelial blistering showed a distinct expression of vimentin in the basal cells 
bordering the blister (Fig. 5C). 
DISCUSSION 
The present study demonstrates that clinically distinguishable benign lesions of the 
vocal cord can show a variety of epithelial phenotypes. These lesions were characterized 
by (hyper)keratosis, hyperplasia and atrophy. In addition, the lamina propria also 
showed various changes. 
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Our ¡mmunohistochemical data on the presence of IFPs showed that the original 
expression pattern of various Cks had changed. In particular, these changes were evident 
in the keratinizing and hyperplastic epithelium. They were characterized by increased 
expression of the keratinization marker Ck 10, the basal cell marker Ck 14 and 
hyperproliferation-associated Cks 16 and 1 7. The Ck expression pattern of atrophic 
epithelium largely resembled that of normal epithelium, except in the keratinized areas. 
The expression of Ck 10 was clearly related to keratinization and was often associated 
with a decrease in the stratification markers Cks 4 and 13. This inverse relation is in line 
with observations made by others in benign epithelial lesions of the oral cavity.15 
Extension of basal cell marker Ck 14 into the suprabasal cell layers and the 
upregulation of Ck 16 indicates hyperproliferation in the benign vocal cords lesions, as 
it does in other epithelial abnormalities.16, '7 In contrast with Ck 14, expression of the 
other basal cell marker Ck 5 did not extend into the suprabasal cells, although it has 
been described that these two Cks form copolymers.18 This phenomenon is difficult to 
explain, but a comparable dissociation between the expression of Cks 5 and 14 has 
been reported in skin under hyperproliferative conditions.'9 
In normal NKSE, Ck 17 is expressed in the basal cell layers. In several of the studied 
lesions the expression of Ck 1 7 had shifted to the supra basal cell layers, while expression 
had decreased in the basal layers. Although Ck 17 is considered to be a marker of basal 
cells of complex epithelia,20 the fact that its expression pattern is similar to that of Ck 16 
in epidermal lesions21 suggests that Ck 1 7 can be considered as a hyperproliferation-
associated cell marker under these conditions. 
The simple epithelial cell markers Cks 8 and 18 were not expressed in the benign 
lesions, except for the basal cells bordering the fluid-filled blisters. This suggests that 
there may bea relationship with this peculiar anatomical position, i.e. bordering a fluid-
filled cavity. The expression of vimentin in these cells can indicate that they have special 
properties. The latter observation agrees with the suggestion made by Kasper et al.22 that 
vimentin is often expressed in the epithelial lining of fluid-filled cavities. 
Ck 19 is generally considered to be a marker of simple and complex epithelia, but 
it is also present in the basal cells of non-keratinizing epithelia in areas of variable or 
labile differentiation, where two types of differentiation coexist, such as the mouth and 
cervix.23 Its extension into the suprabasal cell layers can be assumed to indicate 
disturbance of differentiation. 
The expression patterns of the basal cell Cks 5, 14 in benign lesions were similar to 
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those in laryngeal carcinoma, but the expression of Cks 16 and 17 was more 
pronounced in carcinoma 24 In addition, keratinocytes in carcinoma show marked 
expression of simple cell markers Cks 8 and 18, and often of vimentin The same applies 
to Ck 19, although some carcinomas can be completely devoid of Ck 19 According to 
Lindberg et a l 2 5 and Copper et a l 2 6 the expression of Ck 19 in normal NKSE and 
benign lesions of the oral cavity is related to premalignancy However, the present 
observations of Ck 19 expression in normal NKSE and in benign laryngeal lesions does 
not support this assumption 
We conclude that benign lesions of the vocal cords differ from squamous cell 
carcinomas of the larynx in the expression pattern of simple cell Cks and vimentin This 
may be of use in case of differential diagnosis 
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CYTOKERATIN AND VIMENTIN EXPRESSION 
IN NORMAL EPITHELIUM AND SQUAMOUS CELL CARCINOMAS 
OF THE LARYNX 
ABSTRACT 
The immunohistochemical expression patterns of cytokeratin polypeptides (Ck) and 
vimentm were investigated in normal epithelia and squamous cell carcinomas 
(SCCs) of the larynx with special emphasis on tumor grading During malignant 
transformation of epithelial cells, the cytokeratin expression patterns changed, 
depending on the differentiation grade of the carcinomas In grade 1 carcinomas, 
the expression of stratification markers Cks 4 and 13 was largely decreased Ther 
was an upregulation of the expression of the basal cell markers Cks 1 4 and 1 7 and 
the hyperproliferation-associated marker Ck 1 6 With increasing tumor grade their 
expression decreased Increasing tumor grade was also associated with the 
expression of simple epithelium-related Cks 8 and 18 and of vimentm, a 
cytoskeletal protein of mesenchymal cells Expression of these polypeptides was 
especially marked in tumors with a basaloid phenotype and in tumor margins No 
relationship was found between vimentm expression and the presence of lymph 
node metastases Correlation of intermediate filament expression of SCCs with their 
clinical behavior may show wether the expression profiles have a significant 
prognostic value 
INTRODUCTION 
In the past few years, studies on tumor biology have provided clues for new 
prognostic parameters in affected patients. One of the many approaches in experimental 
oncology has concentrated on intermediate filament proteins (IFPs). IFPs are important 
constituents of the cytoskeleton which exhibit cell-lmeage-specific expression These 
properties make it possible to differentiate between the ma|or classes of malignancies, 
using appropriate monospecific antibodies 
Cytokeratms (Cks) are the IFPs of epithelial cells In man, 20 different Cks have been 
identified in certain combinations. '2 '3 u Their expression depends upon the type of 
epithelium, the place of the cell within the epithelium, and its state of differentiation 
Profound changes in Ck expression have been shown to occur during malignant 
transformation or tumor progression These changes may be related to the degree of 
malignancy and predict the clinical outcome in some tumors 19 In addition, cytokeratin 
subtype expression can be helpful in the subclassification of the different types of 
carcinomas.18 
Ck expression has also been investigated in squamous cell carcinoma (SCC) of the 
larynx 825 These studies, however, have only investigated a small number of Cks due to 
the use of fixed and paraffin-embedded tissues In these preparations, only a limited 
number of Ck subtype-specific antibodies is available that is reactive after tissue has 
been fixed and paraffin-embedded 
In the present study, we evaluated the expression of Cks in the normal laryngeal 
epithelium and in SCC of the larynx and its lymph node metastases in an attempt to 
detect a possible correlation between Ck expression patterns and the histopathologic 
and clinical parameters of the tumors. This study was performed on freshly frozen tissue 
sections, allowing the application of a comprehensive panel of monospecific antibodies 
that represented virtually all Cks In addition, the expression of vimentin, the mesenchym-
al type of IFP, was also studied, since this was previously suggested to have prognostic 
relevance when present in epithelial malignancies4 
MATERIALS AND METHODS 
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N + 
Normal laryngeal mucosa was obtained within ten hours of death from seven autopsy 
cases having no indication of any type of laryngeal disease Multiple tissue samples were 
taken from the various anatomic sites of the larynx Fresh SCC samples were also taken 
from 29 patients following endoscopic biopsies or laryngectomies (Table 1) None of the 
patients had been treated with chemotherapy or radiotherapy prior to surgery Material 
was available from 16 pa-
tients without lymph node 
metastases (N - ) and from 
13 patients with histopath-
ologically proven regional 
lymph node metastases 
(N+) Four of these lymph 
node metastases were an-
alyzed together with the 
primary tumor 
An average of two 
samples was taken from 
the primary tumor and 
lymph nodes The sample 
size varied between 0 5 
and 1 0 cm Histological 
grading and TNM classifi-
cation were performed on 
conventional paraffin sec-
tions according to the recommendations of the International Union Against Cancer5 In 
most tumors three histologically different compartments could be distinguished a basal 
cell compartment, a supra basal intermediateceli compartment, and a third compartment 
containing more differentiated and (pre)keratinizmg cells 
Tumor grade 
Tumor site 
Tumor 
morphology 
1 
2 
3/4 
Suprogloltic 
Glottic 
Transglottic 
keratinocyte-
hke 
basaloid 
mixed 
spindle cell 
component 
2 
10 
4 
10 
5 
1 
11 
0 
2 
3 
1 
7 
5 
11 
1 
1 
5 
3 
5 
0 
Table 1 Grading anatomic site and morphology of 29 squamous cell 
carcinomas of the larynx ( N , n = 16,N + , n = 13) 
Antibodies 
Fifteen different mouse monoclonal antibodies (MAbs) against individual Cks and 
one monoclonal antibody against vimentin were used in this study The MAbs used were 
characteristic of the different types of differentiation' 2 n ,3 '7 21 27 RK5E60 (Ck 10) of 
cornification, 6B10 (Ck 4), 2D7 (Ck 13), and 1C7 (Ck 13) of stratification, AE14 (Ck 
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grl gr2 g r W 
Oc 14 С * 1 7 
III II 1 
grl gr2 gr3/4 grl gr3 gr3M grt gr2 gr3/4 
gr2 grSU grl 0Г2 дгЗМ 
Wnenlin 
grl gr2 gr3/4 
•• heterogeneous homogeneous 
Figure 1. Expression of Cks and vimentin in laryngeal SCC expressed as percentages of positive cells. Grade 
1, n = 3 ; grade 2, n = 1 7 ; grade 3/4, n = 9; spindle-cell component, n = 3. Staining patterns: sparse - Ck 
expression in less than 25 % of the target cells; heterogeneous - Ck expression in 25-75% of the target cells; 
homogeneous - Ck expression in more than 75% of the target cells 
5), RCKI07 (Ck 14), and E3 (Ck 1 7) of basal cells; KA12 (Ck 6) and LL0025 (Ck 16) of 
hyperproliferation; RCK105 (Ck 7), M20 (Ck 8), CK18.2 (Ck 18), RCK106 (Ck 18), LP2 
К (Ck 19), and RCK108 (Ck 19) of simple cells, and RV202 of vimentin. 
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Immunohistochemistr/ 
Immunohistochemistry was performed according to the indirect immunoperoxidase 
technique, as reported previously 2 Tissue sections were examined by two different 
observers When a discrepancy occurred, consensus was reached by pint re-evaluation 
Staining patterns were defined according to the degree of staining percent Staining of 
less than 25% of the target cells represented a sparse staining pattern Positive staining 
of 25 - 75% of the target ceils was recorded as a heterogeneous staining pattern 
Positive staining of more than 75% of the target cells was considered to be a homoge­
neous staining pattern 
RESULTS 
The normal epithelial lining on the laryngeal side of the epiglottis and on the true and 
false vocal cords consisted of non-keratmizing stratified epithelium (NKSE) 
The ventricle was lined by pseudostratified epithelium (PSE) and immature stratified 
epithelium (ISE) ISE was situated between the NKSE and PSE and showed palisadation 
of columnar basal cell layer(s) and suprabasal squamous cells Small areas of PSE could 
also be found on the epiglottis and false vocal cords The subglottic area was lined by 
PSE These findings did not differ significantly between the various cases studied 
A description of the immunohistochemical findings in the normal epithelia and the 
SCCs is given below In several cases, the Ck expression patterns varied between 
different samples For reasons of clarity the most prominent features are reported Unless 
otherwise indicated, the Ck expression patterns in the lymph node metastases did not 
deviate from those of the primary tumors These findings are summarized in a diagram 
in Fig 1 and illustrated in Figs 2 - 5 
Corn/ficafion marker- Ck 10 
In the normal epithelium, sparse expression of Ck 10 as a marker of cornification was 
seen in the superficial compartment of the NKSE (Fig 2A) No expression was found in 
the PSE or ISE 
In SCCs, Ck 10 was expressed in the (pre)keratinizing cells (Fig ЗА) There was a 
decreased expression of Ck 10 with increasing tumor grade (Fig 1 ) 
Cytokeratin and Vimentin Expression in the Larynx 49 
Figure 2. Micrographs of expression patterns of various Cks in normal laryngeal epithelium. A Sparse 
suprabasal expression of Ck 10 (RKSE60) in the NKSE. В Suprabasal expression of Ck 4 (6B10) in the NKSE. 
С High suprabasal expression of Ck 4 (6B10) in the ISE. D Suprabasal expression of Ck 4 (6B10) in the PSE 
of the subglottic region. E Basal en parabasal expression of Ck 1 4 (RCK 107) in NKSE. F Basal expression of 
Ck 14 (RCK 107 in the PSE. G Heterogeneous (para)basal expression of Ck 17 (E3) in the NKSE. H 
Suprabasal expression of Ck 16 (LL0025) in the NKSE. I Homogeneous expression of Ck 8 (M20) in the PSE. 
J Transition zone ISE/NKSE: expression of Ck 8 (M20) in the apical rim of the ISE, but no expression in the 
NKSE. К Heterogeneous basal expression of Ck 1 9 (LP2K) in the NKSE and heterogeneous expression of Ck 
19 (LP2K) in the ISE. 
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Figure 3. Expression patterns of Ck 1 0 as a ramification marker and stratification markers Cks 4 and 1 3 in 
squamous cell carcinomas of the larynx. A Ck 10 (RKSE60) expression in high intermediate cells in Grade 2 
SCC with keratinization. B,C Transition from hyperplastic epithelium to Grade 2 SCC, showing suprabasal 
expression of Ck 4 (6B10) (B) and Ck 1 3 ( 1 C7) (C) in hyperplastic epithelium, but no expression of Ck 4 and 
decreased expression of Ck 13 in SCC. D Homogeneous expression of Ck 13(1 C7) in SCC with spindle cell 
component. E Higher magnification of D. 
Stratification markers - Cks 4 and 13 
Cks 4 and 13 were used as markers of stratification and were expressed homoge-
neously in most of the suprabasal cell layers of the NKSE, ISE, and PSE (Fig. 2B - D). In 
the basal cell layer, scattered cells reacted with these antibodies. 
In SCCs, Cks 4 and 13 showed varying expression patterns in the intermediate 
compartment. The expression of Ck 13 was usually more pronounced than that of Ck 
4 (Fig. 3B,C). The expression decreased with increasing tumor grade. 20 tumors showed 
a sparse expression of Cks 4 and 13. In three out of nine grade 3-4 carcinomas, 
including two cases with a spindle cell component, extensive expression of Ck 4 and/or 
Ck 13 was observed (Fig. 3D,E). These latter data masked the decreased expression of 
these Cks with increasing tumor grade (Fig. 1 ). 
Basal cell marlcers- Cks 5, 14 and 17 
Cks 5 and 14 were expressed in the basal cells of all the types of normal laryngeal 
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Figure 4. Expression patterns of basal cell markers (Cks 5, 14, 17) and of hyperproliferation-associated 
markers (Cks 6, 1 6). A Basal expression of Ck 5 (AE1 4) in Gr 1 SCC. В Homogeneous expression of Ck 14 
(LL002) in Gr 1 SCC. С Heterogeneous expression of Ck 1 7 (E3) in Gr 2 SCC. D Homogeneous expression 
of Ck 6 (KA12) in Gr 3 SCC. E High intermediate staining of Ck 1 6 (LL0025) in Grade 1 SCC with strong 
cornification. F Sparse expression of Ck 16 (LL0025) in Grade 3 SCC with keratinization. 
epithelium (Fig. 2F). In the NKSE, Ck 14 was also present in the the parabasal cells (Fig. 
2E). Expression of С к 17 was limited to the NKSE. In this epithelium, basal and 
parabasal cells showed heterogeneous expression (Fig. 2G). 
In grade 1 carcinomas, basal and sparse intermediate cell staining was observed with 
the Ck 5 antibody (Fig. 4A). Ck 14 was expressed homogeneously in grade 1 - 2 
carcinomas except for the keratinizing areas (Fig. 4B). In the grade 1 tumors Ck 1 7 was 
homogeneously expressed. With increasing tumor grade the expression of Ck 17 
decreased (Fig. 1). There was a preference for the keratinocyte-like cells (Fig. 4C). 
Hyperproliferation-associated markers - Cks 6 and 16 
Ck 6 was expressed homogeneously in all cell layers of the NKSE except for the basal 
cell layer, which showed heterogeneous expression. In the PSE and ISE, Ck 6 revealed 
heterogeneous expression in the basal cells. Ck 1 6 expression was limited to scattered 
areas of suprabasal cells (Fig. 2H). 
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In SCC, Ck 6 was expressed homogeneously in all cell layers of all but one of the 
tumors studied (Fig. 4D), with this latter tumor showing heterogeneous expression. Ck 
16 expression was confined to the intermediate cell compartment and the (pre)keratiniz-
ing cells, often showing a heterogeneous distribution (Fig. 4E). With increasing tumor 
grade, especially in basaloid tumor cells the Ck 16 expression decreased. 
Simple epithelium-related markers- Cks 7,8, 18 and 7 9 
In some of the specimens of NKSE, a sparse parabasal expression of Cks 7, 8, and 
18 was observed. In the columnar cells of PSE and in the suprabasal cells of ISE, Cks 7, 
8 (Fig 21), and 18 were expressed homogeneously. In the ISE, Cks 8 and 18 were 
heterogeneously expressed in the basal cells NKSE ad|acent to the ISE and PSE 
expressed Cks 7, 8, and 18 in the outer cell layers (Fig. 2J) 
Ck 19 was expressed heterogeneously in the basal cell layers of the NKSE (Fig. 2K), 
and a scattering of positive cells was observed suprabasally. In the PSE, Ck 19 was 
expressed homogeneously, while all cell layers in the ISE revealed heterogeneous 
expression (Fig. 2K). 
In grade 1 tumors Cks 8 and 18 were sparsely expressed, but this expression strongly 
increased in the advanced grade of tumors (Figs 1, 5A - C). Ck 7 was less prominent 
and was only found in a scattering of cells in eight of the tumors. One tumor showed a 
heterogeneous expression of Ck 7. Eleven N+ tumors were positive for Cks 8 and 18. 
Expression was especially abundant in tumors with a basaloid cell phenotype, in 
infiltrating tumor strands(Fig. 5B). In ten cases the expression increased towards the 
tumor margins (Fig 5C). All sixteen N - tumors showed expression of Ck 18. Twelfe N-
tumors were positive for Ck 8 In nine mainly grade 1-2 tumors (5N+ and 4N - ), 
sparse or no Ck 19 expression was observed. In 8 grade 3-4 tumors Ck 19 showed at 
least a heterogeneously expression in all cells (Figs. 5D,E). 
Mesenchymal specific cytoskeletal protein - Vimenfin 
No expression of vimentin was observed in the normal laryngeal epithelium In 7 N-
and in 8 N + tumors vimentin expression was observed in the epithelial tumor cell 
compartment Seven tumors hada basaloid ora mixed cell phenotype Two tumors, with 
a spindle cells component also expressed vimentin. Vimentm expression was especially 
marked in small infiltrating tumor strands (Fig. 5F). All of the vimentm positive tumors 
showed abundant expression of simple epithelial Cks. In contrast to primary tumor, 
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Figure 5. Expression patterns of simple cell-related markers (Cks 8,18,19) and vimentin in SCC of the larynx. 
A Heterogeneous expression of Ck 18 (RCK 106) in Grade 2-3 SCC. В Homogeneous expression of Ck 18 
(RCK 106) in Grade 3 SCC, with basaloid phenotype. С Expression of Ck 8 (M20) in infiltrating tumor strands 
in Grade 2-3 SCC. D Heterogeneous expression of Ck 19 (LP2 K) in Grade 2 SCC. E Homogeneous 
expression of Ck 1 9 (RCK 108) in Grade 3 SCC, with central necrosis. F Vimentin expression in basal cells 
in Grade 3 SCC. 
vimentin expression was absent in the lymph-node metastases. 
DISCUSSION 
The Ck expression patterns observed in both the PSE and NKSE of the larynx were 
generally consistent with the findings reported previously in the epithelia in other areas 
of the respiratory tract.2 However, the presence of some specific Cks in the normal 
laryngeal epithelium deserves special attention. For example, the expression of Cks 6 
and 1 6 has been correlated with hyperproliferation.29 These Cks are present in epithelia 
during wound repair28and pathologic conditions associated with hyperproliferation,29 as 
well as in epithelia having a high cell turnover, such as the oral mucosa.15 Therefore, 
their presence in the normal laryngeal epithelium can be assumed to refer to the 
existence of a high cell turnover in this epithelium. 
Ck 19 was expressed in both the basal and suprabasal cell layers of the normal 
laryngeal NKSE. The suprabasal expression of Ck 19 has been reported as an early 
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event in malignant transformation.7 However, our finding of this Ck in normal NKSE and 
its absence in four of our cases of laryngeal SCC are reasons to question whether Ck 19 
can be considered as a true transformation marker. Absence of Ck 19 expression has 
also been reported in tissue samples of SCC of the pyriform sinus and oral cavity.3, ,6 
Our study demonstrates that profound changes in the Ck phenotype of the laryngeal 
epithelium can occur in certain cases following malignant transformation and tumor 
progression. These changes are related to the degree of cellular differentiation and 
keratinization. All Cks expressed in the normal NKSE are present, but their expression is 
altered. Most low grade carcinomas showed a profoundd decreased of the startificaton 
markers Cks 4 and 13, while the basal cell markers Cks 14 and 17 and the 
hyperproliferation-associated Ck 16 was largely increased. Ck 10 expression was related 
to keratinization. 
Changes in the Ck phenotype of the laryngeal epithelium upon malignant 
transformation differ from those observed in a previous study on various benign lesions 
ot the vocal cords.27 The main differences are the lack of expression of simple Cks 8 and 
18 and vimentin. In benign lesions Cks 8 and 18 are generally absent. They are only 
expressed in epithelial cell bordering subepithelial blisters. 
With increasing tumor grade, the Ck distribution pattern was found to change 
gradually. These changes were mainly characterized by a loss of the stratification 
markers Cks 4 and 13 and a decrease of Cks 14, 1 7 and 16. The Cks typical of simple 
epithelia (Cks 8, 18, and 19) showed an increased expression. In addition, vimentin 
expression was also apparent with increasing tumor grade. These observations were very 
similar to those described in SCCs of the lung.1 
The decreased expression of the stratification markers Cks 4 and 13 in the majority 
of laryngeal tumors has also been reported in several types of SCCs.1,6 This down-
regulation of stratification markers seems to be associated with a loss of differentiation 
of the SCCs. However, the abundant expression of Cks 4 or 13 in three of our grade 3 
- 4 tumors appears to be in conflict with this assumption and is difficult to explain. 
According to Mallofré et al.8, there is a close relationship between the loss of Ck 13 and 
Ck 16, as demonstrated with the antibody Ks8.12, and the presence of cervical lymph 
node metastases. However, our present observations do not confirm this assumption. 
Cks 5 and 14 are both basal cell markers and are expected to be synthesized in a 
one-to-one ratio, but their expression levels differed largely in laryngeal SCCs. In contrast 
to the abundant Ck 14 expression in grade 1 - 2 SCCs, Ck 5 showed very low 
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expression. Although similar observations have been made by Vaidya et al.26 in buccal 
carcinomas, use of the same MAb in other studies showed an abundant expression of 
Ck 5 in SCC of the cervix.23,2" This phenomenon is probably due to epitope masking or 
changes in epitope configuration. 
Expression of simple epithelial cell Cks has been observed in SCCs of various 
epithelia.9,22'30 The marked expression of Cks 8 and 18 has usually been associated with 
vimentin expression at the invasion front of the higher grade tumors and deserves special 
attention. This phenomenon has also been reported at the invasion front of other 
carcinomas22 and suggests a possible relationship with enhanced cell mobility and 
invasive properties of tumor cells in these areas. Vimentin expression has been correlated 
in part with a poor prognosis in breast carcinomas.4,20 However, this assumption is 
somewhat contradicted by the absence of vimentin in our lymph-node metastases studied 
despite its expression in primary tumors that were both node-negative and node-positive. 
Our present study indicates that changes in cytokeratin phenotype may be helpful in 
the differential diagnosis of lesions of the larynx and in malignant grading. In addition, 
Ck expression may also possibly show the existence of other features of tumor cells not 
established by conventional histopathology. Correlation of the Ck profiles of an SCC 
with its clinical behavior may show whether these profiles have a significant prognostic 
value. 
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EXPRESSION OF INTERMEDIATE FILAMENT PROTEINS IN BENIGN 
LESIONS OF THE ORAL MUCOSA 
ABSTRACT 
Immunohistochemistry with monospecific antibodies was used to study the 
expression patterns of cytokeratins (Cks) and vimentin in non-dysplastic lesions of 
the oral cavity, including lichen planus and fibroma In hyperplastic lestons, Ck 
expression did not deviate significantly from the normal non-keratinizing squamous 
epithelium of the oral cavity Hyperkeratotic lesions showed pronounced aberrations 
in their Ck profile These lesions were characterized by extended expression of the 
keratinization marker Ck 10, the basal cell Ck 14 and the hyperproliferation-
associated Ck 16 in the suprabasal compartment The stratification markers Cks 4 
and 13 showed a decreased expression Coexpression of Cks and vimentin was 
found in lesions having accumulations of inflammatory cells in the subepithelial cell 
layer These changes are felt to characterize benign mucosal lesions without 
dysplasia and might be helpful for distinguishing these lesions from potentially 
malignant ones 
INTRODUCTION 
Mucosal lesions in the oral cavity are frequently encountered and mostly presentas 
white lesions of the mucosal lining Histologically, these lesions can include a variety of 
histopathological diagnoses with or without epithelial dysplasia, such as hyperkeratosis, 
fibroma, hyperplasia and lichen planus ruber (LPR) Only white lesions or plaques that 
cannot be characterized clinically or histopathologically as any other disease are termed 
leukoplakia2 
Lymphocytic mucositis and lymphocyte transmigration into the epithelial compart-
ment, associated with keratmization characterize LPR 7 The ma|onty of these lesions 
comprise a benign hyperkeratosis and only incidentally undergo malignant transforma-
tion 
Cytokeratins (Cks) are the intermediate filament proteins of epithelial cells, which 
have become important markers for the study of normal and abnormal cell differentia-
tion ' 2 , 3 The expression patterns of the 20 different subtypes are site-specific and may 
change when the growth rate and/or level of differentiation are altered pathologically 
These properties mean that the application of monospecific antibodies (MAbs) against 
different Cks can be useful for the evaluation of premalignant changes in epithelial cells 
As oral mucosal lesions will show a disturbed epithelial differentiation we reasoned 
that different expression patterns of Cks might contribute to distinguishing between 
benign and potentially malignant lesions In the present study Ck expression was studied 
in clinically benign lesions of the oral cavity by using monospecific Ck antibodies 
recognizing the various lineages of epithelial differentiation In addition, the expression 
of vimentin, the mesenchymal type of IFP, was investigated, because coexpression of Cks 
and vimentin has been described in epithelial cells under various pathological conditions 
including premalignancy ' 6 2 1 
MATERIALS AND METHODS 
Freshly excised tissue samples were obtained from 18 clinically benign lesions of non-
keratinizing squamous epithelium (NKSE) of the oral cavity The lesions comprised buccal 
mucosa (n= 8), gingiva (n= 4), soft palate (n= 2), tongue (n= 3) and lip mucosa (n = 
1) These patients had no history of premalignant or malignant tumors of the upper 
respiratory tract 
Seven autopsy cases without histories of diseases of the head and neck were used as 
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controls and multiple biopsies of normal epithelium were taken from comparable 
subsites within 10 hours after death 
Immediately after dissection all specimens were frozen in liquid nitrogen and stored 
at -80°C Cryostat sections (5 /Lim thick) were stained with hematoxylin-eosin for 
histological examination or processed for immunohistochemistry Immunohistochemistry 
was performed according to the indirect immunoperoxidase technique as described 
previously20 
Fourteen different mouse MAbs against individual Cks and one MAb against vimentin 
were applied to characterize the different types of differentiation RKSE60 (CklO) for 
keratimzation, 6B10 (Ck 4), 1C7 and 2D7 (Ck 13) for stratification, AE14 (Ck5), 
RCK107 (Ckl4) and E3 (Ckl7) for basal cells, KA12(Ck6) and LL025 (СИ 6) for 
hyperproliferation, RCK105 (Ck7), M20 (Ck8), RCK106 (Ckl8), LP2K (Ck 19) and 
RCK108 (Ck 1 9) for simple epithelial cells and RV202 for vimentin Sources and further 
specifications have been detailed b e f o r e 4 5 6 , Э 2 0 2 2 24 26 71 
The staining patterns obtained with the different antibodies were evaluated semi-
quantitatively Immunostainmg of >75% of the target cells was defined as homoge­
neous Immunostaining of 25-75% of the target cells was defined as heterogeneous and 
immunostainmg of <25% of the target cells was defined as a reaction in a minority of 
the cells 
RESULTS 
The control specimens from comparable oral subsites were lined by NKSE Only a 
patchy distribution of keratinizing squamous epithelium (KSE) was found in the specimens 
obtained from the dorsal lining of the tongue The NKSE showed rete ridges, which 
varied in size at the various subsites In specimens obtained from the floor of the mouth, 
no rete ridges were observed 
The 18 benign lesions comprised hyperplastic lesions without keratimzation (n= 6), 
hyperplastic lesions with partial keratimzation (n= 4), LPR (n= 3), hyperkeratosis (n= 3) 
and fibroma (n= 2) The various lesions showed both ortho- and parakeratosis Four 
lesions, one case of hyperkeratosis and three cases of LPR showed distinct lymphocytic 
infiltration in the lamina propria 
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Figure 1. Immunohistochemical staining of control NKSE of the oral cavity with antibodies against various Cks. 
A: Ck 10 (RKSE60); B: Ck 1 3 (1C7); C: Ck 14 (RCK 107); D: Ck 16 (LL025); E: Ck 1 8 (RCK 106) reacting 
with Merkel cells, F: Ck 19 (LP2K) 
N o relation could be established between the pathological features of the lesions and 
their oral subsite. None of these patients developed an oral squamous cell carcinoma 
throughout a fol low up period of 4-5 years. 
The Ck profile of the specimens was described according to the different types of 
epithelial differentiation. These results are illustrated in Figs. 1-2, while the most 
conspicuous findings are summarized in Fig. 3. 
Cornification marker - Ck 10 
In the control specimens, NKSE generally showed no or only sparse suprabasal 
expression of С к 10 (Figs. IA, 3). Heterogeneous suprabasal expression was observed 
in the control specimens obtained from the base of the tongue. 
In the hyperkeratotic lesions, Ck 1 0 was expressed homogeneously in the suprabasal 
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Figure 2. Immunohistochemical staining of leukoplakia specimens showing hyperkeratosis (Α-E) with antibodies 
against various Cks. A: Ck 10 (RKSE60); B: Ck 13 (1C7); C: Ck 14 (RCK107); D: Ck 1 7 (E3); E: Ck 16 
(LL025) F: Leukoplakia with subepithelial accumulation of lymphocytes showing vimentin expression in basal 
cell layers of epithelium (antibody RV202) 
cell layers, except for the stratum corneum (Figs. 2A, 3). In hyperplasia with partial 
keratosis Ck 10 showed a heterogeneous suprabasal expression pattern, especially in 
the prekeratinizing cells. Sparse suprabasal expression was found in hyperplasia without 
keratinization and in the LPR lesions (Fig. 3). The fibromas revealed heterogeneous 
suprabasal expression of Ck 10. 
Stratification markers - Ocs 4 and 13 
Cks 4 and 13 showed homogeneous suprabasal expression in the NKSE of the 
control specimens (Figs. 1 B, 3). No expression was seen in the small rete ridges. 
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Hyperplastic lesions without keratinization revealed homogeneous expression of CK 
4 and 13 in the suprabasal cell layers (Fig 3) In lesions with partial keratosis such as 
hyperplasia, fibroma and LPR, the suprabasal cell layers showed sparse to heteroge­
neous expression of Cks 4 and 13 (Fig 3) Similar expression was observed in the 
suprabasal cell layers in hyperkeratotic lesions (Figs 2B, 3) 
Basal cell markers - Cks 5, 14 and 17 
Cks 5 and 14 were expressed homogeneously in the basal cell layer of control NKSE, 
while Ck 14 was also sparsely expressed in the parabasal layer (Figs 1С, 3) The 
expression of Ck 17 was confined to the NKSE of the tongue, where sparse suprabasal 
expression was observed (Fig 3) No expression was found in the NKSE at other subsites 
Lesions without keratinization and the fibromas showed homogeneous basal 
expression of Cks 5 and 14 and heterogeneous expression of Ck 14 in the suprabasal 
cell layers (Fig 3) Similar expression was observed in the hyperkeratotic lesions and 
hyperplastic lesions with keratinization, but in these lesions Ck 14 was virtually absent in 
the upper cornifying layers (Fig 2C) LPR showed a homogeneous basal expression and 
a sparse suprabasal expression of Ck 14 (Fig 3) Ck 17 was expressed heterogeneously 
in the suprabasal cell layers and was sparse in the basal cells of lesions with keratinizat­
ion (Figs 2D, 3) In lesions without keratinization and the fibromas Ck 1 7 was only 
sparsely expressed (Fig 3) 
Hyperprol/feraf/on-assocrafed markers - Cks 6 and 7 6 
In the control NKSE, Ck 6 showed homogeneous suprabasal expression In the basal 
cells, Ck 6 was expressed heterogeneously Homogeneous expression of Ck 6 was seen 
in all cell layers of the small rete ridges Ck 16 showed sparse suprabasal expression in 
NKSE without rete ridges (Fig 1 D), but heterogeneous expression was observed in NKSE 
with rete ridges 
All lesions showed homogeneous expression of Ck 6 
In the lesions with keratinization Ck 16 was expressed nearly homogeneously in the 
suprabasal cell layers except for the stratum corneum (Figs 2E, 3) In the absence of 
keratinization and LPR only sparse expression of Ck 16 was observed (Fig 3) 
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Figure 3 Overview of Ck expression patterns in control epithelium, (hyper)keratotic lesions, hyperplastic lesions 
and lichen planus ruber of the oral cavity 
(1) - hyperplastic lesions with partial keratosis ore included 
(2) - two fibromas are included 
(3) - one hyperkerototic lesion with subepithelal lymphocyte infiltration is included 
B= basal cell layer, SB= suprabasal cell layer 
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Simple epithelium-related markers - Cks 7,8, 18 and / 9 
Distinct expression of Cks 8 and 18 was present in the Merkel cells of the gingiva and 
in the glandular ducts (Fig. 1 E). A similar observation was made in the majority of 
lesions, especially in the fibromas. Expression of simple epithelial cell markers was absent 
in the epithelial cells of NKSE with the exception of Ck 19. Ck 19 was expressed 
heterogeneously in the basal cell layers and was sparse in the suprabasal cell layers 
(Figs. IF, 3). In the small rete ridges, all basal cells expressed Ck 19, but in the larger 
rete ridges, expression was confined to the lateral sides. 
Lesions did not express Cks 7, 8 and 18, while the majority of lesions also lacked Ck 
19 expression (Fig. 3). Only three hyperplastic lesions with distinct rete ridges showed 
homogeneous basal cell expression and sparse suprabasal cell expression of Ck 19. In 
LPR (Fig. 3) and in the hyperkeratotic lesion with subepithelial lymphocyte infiltration a 
sparse basal expression of Ck 19 was observed. 
Mesenchymal specific cytoskeletal protein - vimentin 
In the control oral mucosa, the dermis showed abundant expression of vimentin. No 
expression was observed in the epithelium. In four lesions with comprehensive 
lymphocytic infiltration of the subepithelial compartment (LPR n= 3, hyperkeratosis n = 
1) vimentin was expressed in the basal epithelial cell layers (Fig. 2F). 
DISCUSSION 
Our study has demonstrated that normal NKSE of the oral cavity is characterized by 
the homogeneous expression of Cks 5 and 14 in basal cells, whereas stratification 
markers Cks 4 and 13 are expressed homogeneously in the differentiation compartment. 
In addition, Ck 19 show sparse expression in the basal layers and heterogeneous 
expression in the differentiation compartment. Cks 6 and 16, hyperproliferation-
associated Cks, are expressed to a varying extent in the differentiation compartment. This 
reflects a high keratinocyte turnover. These data are generally consistent with other 
reports on NKSE in the oral cavity.,4,19 
The expression of Ck 17 is difficult to interpret. In the oral cavity, Ck 17 is expressed 
sparsely in the suprabasal cell layers. Ck 1 7 is generally classified as a basal cell marker 
of a group of complex epithel ial However, in NKSE the basal expression of Ck 1 7 is 
rare. No expression is encountered in the adult esophagus,23 while a heterogeneous 
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(para)basol expression is found in the NKSE of the larynx.24 In normal epidermis, Ck 1 7 
expression is absent, but under conditions of hyperproliferation Ck 1 7 has been observed 
in psoriasis9 and cholesteatoma.28 In these cases, Ck 1 7 expression was closely related 
to the expression of Ck 16. These findings, together with the similarity of the expression 
pattern of Cks 16 and 17 in keratinizing benign lesions of the oral cavity and larynx, 
suggest that Ck 17 can be classified as a hyperproliferation marker.28 
According to Lindberg and Rheinwald1 ' suprabasal expression of Ck 19 is correlated 
with mucosal instability and premalignant changes. However, variable suprabasal 
expression patterns of Ck 19 can also be found in normal oral epithelium22 and in the 
NKSE of the larynx.26 
Hyperplasia and hyperkeratosis, occasionally associated with inflammation, 
characterized the benign lesions studied by us in these sites lined by NKSE. Ck expression 
in hyperplastic lesions did not differ significantly from that observed in the normal NKSE 
taken from the comparable subsites, except for suprabasal expression of the basal cell 
marker Ck 14. 
Hyperkeratotic lesions demonstrated profound changes in the site-specific Ck profile. 
They were characterized by a loss of stratification markers Cks 4 and 13, associated with 
upregulation of the keratinization marker Ck 10. In both hyperplastic and hyperkeratotic 
lesions Ck 19 was absent, except for the lesions showing inflammation. This relationship 
is consistent with the observations made by Bosch et al.,3 who suggested that the 
inflammatory response in leukoplakia is responsible for Ck 19 expression. The Ck profile 
of the oral hyperkeratotic lesions revealed a striking similarity with the Ck profile 
observed in hyperkeratosis in the epithelium of the vocal cord.26 
LPR and fibrous hyperplasia are distinct histopathological entities among the 
leukoplakic lesions. However, their Ck profiles appear to depend mainly on the 
hyperplasia or hyperkeratosis of the epithelial compartment as observed in the other 
lesions. 
Vimentin and Cks were coexpressed in several lesions. So far, such coexpression has 
been observed in normal epithelial cells during development,5,10 in epithelial cells in 
tissue culture8 and in carcinomas, including carcinomas of the oral cavity.',21'28 Our 
present observations suggest a close relationship between inflammation and vimentin 
expression in non-dysplastic lesions of the oral cavity. 
Our present findings on Ck expression of the benign lesions studied only partly agree 
with earlier reports.,5'17,28 The main difference was the expression of simple epithelial 
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cytokeratins 8 and 18. However, other reports noted the expression of Cks 8 and 18 was 
correlated with epithelial dysplasia, but this finding was absent in the lesions of our study. 
In squamous cell carcinoma of the oral cavity Ogden et al. 18 reported the presence of 
simple epithelium-related Cks. In an unpublished study from our laboratory we 
established that Cks 8 and 18 were also expressed in dysplastic areas adjacent to some 
tumors.29 This observation suggests a correlation between the expression of Cks 8 and 
18 and premalignant changes. This may mean that the expression of these cytokeratins 
can help to differentiate between benign and potentially malignant lesions. Support for 
this assumption can be derived from the observation that none of the patients of our 
present study developed an oral malignancythroughoutafollowup period of 4-5 years. 
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CHAPTER 5 
EXPRESSION OF CYTOKERATIN SUBTYPES AND 
VIMENTIN IN SQUAMOUS CELL CARCINOMA OF THE 
FLOOR OF THE MOUTH AND THE MOBILE TONGUE 
Lilly-Ann van der Velden, H. Ewout Schaafsma, Johannes J. 
Manni, Frans CS. Ramaekers, Wim Kuijpers 
SUBMiïTED 
EXPRESSION OF CYTOKERATIN SUBTYPES AND VIMENTIN IN 
SQUAMOUS CELL CARCINOMA OF THE FLOOR OF THE MOUTH 
AND THE MOBILE TONGUE 
ABSTRACT 
The expression patterns of cytokeratm polypeptides (Ck) and of vimentin have been 
studied in normal epithelium of the mobile tongue and floor of the mouth, 
squamous cell carcinomas and their lymph node metastases Chain-specific 
monoclonal antibodies to various Cks and to vimentin were used, employing the 
immunoperoxidase technique Profound changes in the expression of pre-existing 
Cks and de novo expression of simple epithelium-related Cks and of vimentin 
occurred upon malignant transformation and tumor progression Changes were 
mainly related to the type of differentiation, tumor growth pattern and grade Low 
grade tumors showed a pronounced decrease of the stratification Cks 4 and 13 and 
an increase of Cks 14, 16, and 1 7 With increasing tumor grades, expression of 
these Cks decreased De novo expression of Cks 8 and 18 and of vimentin was 
most marked in high grade tumors, in tumors with a basaloid phenotype, or tumors 
growing in small infiltrating tumor fields The coexpression of Cks and vimentm was 
proposed to be associated with poor prognosis 
INTRODUCTION 
Squamous cell carcinoma (SCC) of the epithelial lining of the upper aerodigestive 
tract is among the most common malignancies world-wide.' It is most commonly located 
in the oral cavity. The incidence of its tumors is steadily increasing due to well-known 
risk factors such as smoking, alcohol consumption and chewing of betel nuts.2 
Oral cancer has a high mortality rate, with a five-year survival rate of about 35%. The 
existing TNM classification of SCC of the head and neck region is clearly insufficient for 
optimal prognostication and planning of treatment. It does not include other factors 
which reflect biological behavior of tumor cells, such as differentiation grade, perineural 
growth, intravascular growth, and extracapsular spread. Further attempts to identify and 
assess factors that can predict the clinical outcome of these tumors are needed to better 
classify the lesions so as to select treatment modalities with the least functional and/or 
cosmetic consequences. 
To improve the diagnosis of epithelial tumors, characterization of their intermediate 
filament content is increasingly being applied.3 In man, 20 different cytokeratins (Cks) 
have been identified.'*'5 Cks are the intermediate filament proteins (IFPs) occurring in 
specific combinations in the different types of epithelia, depending on the degree and/or 
type of differentiation. After neoplastic transformation, the typical Cks are often retained 
in the tumorogenic tissue, but additional Cks may be expressed in the same cells. ' 
Vimentin, an intermediate filament protein that is normally found in mesenchymal tissues, 
can also be expressed de novo in epithelial malignancies, and has been suggested as 
an indication of a poor prognosis.7,8 Close examination of these expression patterns may 
lead to better insight in the biological behavior of SCCs of the oral cavity. To determine 
their value in predicting tumor behavior, the present study investigates the expression of 
Cks and vimentin in SCCs of the mobile tongue and floor of mouth (FOM) in relation 
to tumor morphology, growth pattern, and degree of tumor differentiation and lymph 
node metastases. 
MATERIALS AND METHODS 
Tissues 
Thirty-six fresh samples of SCC of mobile tongue and floor of the mouth were 
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N-
Tumor grade 
Tumor site 
Tumor morphology 
1 
2 
3 
FOM 
tongue 
keratinocyte-like 
basaloid 
mixed 
6' 
θ 
3 
9 
8 
10 
5 
2 
1 
142 
43 
9 
10 
9 
6 
4 
obtained during 
surgery and snap 
frozen in liquid 
nitrogen after re­
section. None of 
the patients were 
treated with che­
motherapy or ra­
diotherapy prior to 
surgery. A sum­
mary of the degree 
of differentiation, 
the anatomical Table 1. Grading, anatomic site and morphology of 36 SCCsof FOMond mobile 
site, the morpholo- |™aue used m ih., study. 
I. Includes 3 carcinomas in situ / microinvasive carcinomas 
gy and the growth 2. Four lymph node metastases examined in addition to the primary tumor 
3. Three lymph node metastases examined in addition to the primary tumor 
pattern of the ma­
jor cell population is provided in Table 1. Material was available from 1 7 patients 
without lymph node metastases (N-) and from 19 patients with histopathologically proven 
regional lymph node metastases (N+). Seven tumors showed severe dysplasia next to the 
tumor border. These areas were included in the study. Histological grading was 
performed on hematoxylin-eosin (Η-E) stained paraffin sections. Multiple biopsies of 
normal epithelium taken within 10 hours after death from the same subsites from seven 
autopsy cases without a history of oral diseases served as a control. 
An average of two tissue samples was taken from the primary tumor and from the 
lymph nodes. The sample size varied between 0.5 and 1.0 cm3. Histological grading was 
performed on conventional H-Ε stained paraffin sections. 
In most tumors three histologically different compartments could be distinguished, 
i.e., a basal cell compartment, a suprabasal (intermediate) cell compartment and a 
compartment containing (pre) keratinizing cells. 
Antibodies and ¡mmunohistochemistry 
Fourteen different mouse monoclonal antibodies (MAbs) directed against individual 
Cks and one MAb for vimentin were used in this study. The MAbs reacted characteristi-
cally with the different types of epithelial differentiation: RKSE60 (Ck 10) for cornification; 
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6B10 (Ck 4), 2D7 and 1C7 (Ckl 3) for stratification, AE14 (Ck 5), RCK107 (Ck 14) and 
E3 (Ck 1 7) for basal cells, KA12 (Ck 6) and LL0025 (Ck 16), which is presumed to be 
a hyperproliferation-assoaated marker, but is also suggested to be correlated to 
squamous differentiation,9 RCK105 (Ck 7), M20 (Ck 8), RCK106 (Ck 18), LP2K and 
RCK108 (Ck 19) for simple epithelial cells RV202 is an MAb directed against vimentin 
For detailed information on their specificity and reactivity patterns see references 4, 5, 
10, 11, 12, and 13 Immunohistochemistry was performed according to the indirect 
immunoperoxidase technique as reported previously 12 
The paraffin and cryostat sections were classified separately by two observers In the 
case of discrepancy, a consensus was reached by |oint re-evaluation 
The immunostaimng patterns were defined as follows, sparse staining pattern 
staining of less than 25% of the target cells, heterogeneous staining pattern a positive 
staining of 25% to 75% of the targe1 ceils A positive staining of more than 75% of the 
target cells was defined as homogeneous staining 
RESULTS 
A description of the expression patterns of the investigated Cks and of vimentin in 
non-keratinizing stratified epithelium (NKSE) of the mucosal lining of the oral cavity and 
the SCCs specimens is given below In several specimens the Ck expression patterns 
varied between different samples For the sake of clarity the most salient features are 
reported Unless otherwise indicated the Ck expression patterns in the lymph node 
metastases did not deviate from those of the primary tumors 
The findings are summarized diagrammatically in Fig 1 and illustrated in Figs 2-4 
Cormficaf/on marker - Ck 10 
NKSE of the normal oral mucosa showed sparse to no expression of Ck 10 
Specimens obtained from the base of the tongue showed heterogeneous suprabasal 
expression 
In the SCCs, a close relationship existed between the expression of Ck 10 and a kera-
tinocyte-like phenotype The maprity of the tumors showed sparse to no expression of 
Ck 10 (Fig 2A) A minor number of the tumors growing in large tumor fields or having 
a pushing border showed homogeneous expression Ck 10 was sparsely expressed in 
the (pre)keratmizmg cell layers of basaloid tumors or in tumors consisting of a mixed cell 
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Figure 1. Expression of cytokeratins and vimentin in laryngeal SCC expressed as percentages of positive cases. 
Grade (Gr) 1, n = 3 ; Gr 2, n = 17; Gr 3/4, n = 9 ; spindle-cell component, n = 3 . Staining patterns: sparse: 
Ck expression in 0-25% of the target cells; heterogeneous: Ck expression in 25-75% of the target cells; 
homogeneous: Ck expression in 75-100% of the target cells. 
type (eosinophilic and basaloid). Tumors which grew in small infiltrating tumor fields 
showed sparse to no expression. 
In one lymph node metastasis the expression of Ck 10 was more pronounced than 
in the primary tumor. This metastasis consisted of keratinocyte-like tumor cells, while the 
primary tumor showed a mixed cell phenotype. 
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Figure 2. Expression of several Cks in grade 2 SCCs of the tongue. A Cornification marker Ck 10 (RKSE 60) 
is sparsely expressed in the prekeratinizing cell layers. В Sparse expression of stratification marker Ck 4 (6B10) 
in scattered suprabasal cells. С Homogeneous expression of basal cell marker Ck 14 (RCK107) in all cell 
layers. D Suprabasal expression of hyperproliferation-associated marker Ck 1 6 (LL0025) in the suprabasal 
tumor cells. E Expression of marker mesenchymal cells vimentm in stroma and (para)basal cell of tumor. 
Stratification markers - Cks 4 and 13 
In NKSE Cks 4 and 1 3 were homogeneously expressed in the suprabasal cell layers, 
but they were absent in the shallow rete ridges. 
Grade 1 SCCs showed a heterogeneous to homogeneous expression of Cks 4 and 
1 3 in about half of the tumors studied. In the higher tumor grades their expression was 
decreased (Fig. 2B). In part of the tumors either Ck 4 or Ck 13 was expressed. 
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Figure 3. Expression of Ck 1 8 and vimentin in two different SCCs of the tongue. A shows expression of Ck 18 
(RCK106) in the basal cell of small tumor strands in a grade 3 SCC. В Expression of vimentin (RV202) in 
parabasal cells and infiltrating strands of a grade 2 SCC of the tongue. 
Basal cell markers - Cks 5, 14, and 1 7 
Cks 5 and 14 were homogeneously expressed in the basal cell layer of NKSE. 
Expression of Ck 17 was limited to a sparse expression in the suprabasal cell layers of 
NKSE of the tongue. 
In SCCs, Ck 5 was expressed in the (para)basal cells and the expression decreased 
with increasing tumor grade. Seventeen tumors did not express Ck 5. A sparse expression 
was seen in 10 tumors. In 7 out of 8 tumors growing in large tumor fields Ck 5 was 
heterogeneously expressed. In the lymph node metastases expression of Ck 5 was 
generally more pronounced than in the primary tumor. 
Ck 14 was expressed in all cell layers of all SCCs (Fig. 1) except for the areas with 
para- and orthokeratosis (Fig. 2C). 
Ck 1 7 showed a homogeneous to heterogeneous expression in the suprabasal cell 
layers. The expression decreased with increasing tumor grade (Fig. 1) 
H/perproliferaf/'on-assoc/'ated markers - Cks 6 and 16 
In NKSE, Ck 6 was homogeneously expressed in the suprabasal cells. Ck 1 6 showed 
showed heterogeneous expression in the basal cells and sparse expression in the 
suprabasal cells. In NKSE with rete ridges this expression was heterogeneous. 
All SCCs and the lymph node metastases revealed a homogeneous expression of Ck 
6 in all cell layers. 
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Ck 16 was expressed in the more differ-
entiated suprabasal cell layers, especially in 
the prekeratinizing cells (Fig. 2D). All tu-
mors with a basaloid phenotype showed a 
sparse expression of Ck 1 6. Homogeneous 
expression was observed in all 8 tumors 
growing in large tumor fields, whereas 
tumors growing in small infiltrating fields 
showed no expression of Ck 16. In high 
grade tumors Ck 16 was less expressed 
(Fig. 1). In the lymph node metastases 
expression of Ck 1 6 was more pronounced 
than in the primary tumors. 
Simple epithelium-related markers - Cks 7, 
8, 18 and 19 
Normal NKSE lacked expression of Cks 
7, 8, and 1 8. Ck 19 was heterogeneously 
expressed in the basal cells and showed a 
sparse suprabasal expression. 
Twenty-two SCCs showed expression of 
Cks 8 and 1 8. Coexpression of Ck 7 was 
found in 1 3 of these tumors. In the majority 
of the tumors Cks 8 and 1 8 showed only 
sparse expression. Homogeneous expressi-
on was observed in part of the high grade 
tumors (Fig. 1). The expression was most 
marked in the (para)basal cell layers, espe-
cially in the borders of small infiltrating 
tumor strands (Fig. ЗА) and in tumors with 
a basaloid phenotype (Fig. 4A). In tumors 
with pushing borders or growing in large 
tumor fields a sparse to heterogeneous 
expression was observed. In this group 
(RCK106) A and of vimentin (RV202) В in a grade 3 
SCC of the tongue with a basaloid cell phenotype and 
central necrosis. 
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expression of Ck 18 was more pronounced than that of Ck 8. 
Ck 19 was expressed in 26 SCCs. In comparison with the other simple epithelium-
related markers Ck 19 showed a more extensive expression, which increased with 
increasing tumor grade (Fig. 1). 
Mesenchyme/ Specific Cytoskeletal Protein - Vimentin 
Vimentin was not expressed in normal NKSE. Thirty SCCs showed expression of 
vimentin 
A minor number of the grade 1 and 2 tumors showed sparse expression of vimentin 
in the (para)basal cells (Fig. 2E). With increasing tumor grade, staining became more 
extensive; in the grade 3 tumors about half of the specimens showed homogeneous 
expression (Fig. 1). Expression was especially marked in basaloid tumor cells and in 
small infiltrating tumor strands (Figs 3B, 4B). Vimentin was coexpressed with Cks 8 and 
18 in the (para)basal cells in nearly all cases. Four out of 12 tumors growing in large 
tumor fields or with pushing borders did not show vimentin expression. The lymph node 
metastases generally showed equal expression as the primary tumors. 
Ck expression in dysplastic epithelium adjacent to SCCs 
The Ck expression in the dysplastic areas shows generally the same features as in the 
primary tumor. In dysplasia next to tumors with a keratinocyte-like phenotype, Cks 10, 
16, and 1 7 were expressed to a varying extent. In general the expression of Ck 14 was 
similar to that in the tumors, but the expression of Cks 4 and 13 was more pronounced. 
The simple epithelium related Cks 8, 18, and 19 were only expressed in the dysplastic 
areas when they were also present in the primary tumor. No expression of Ck 7 was 
observed. In two dysplastic areas vimentin was present in scattered basal cells. 
DISCUSSION 
The present immunohistochemical study on the expression of Cks demonstrates that 
following malignant transformation and tumor progression profound changes can occur 
in the Ck phenotype of oral epithelium. 
Normal NKSE of the oral cavity was characterized by homogeneous expression of 
Cks 5 and 14 in the basal cells, whereas stratification markers Cks 4 and 13 were 
homogeneously expressed in the supra basal compartment. Hyperproliferation-associated 
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markers Cks 6 and 16 were expressed to a varying extent in the suprabasal cells. Except 
for Ck 19, the simple epithelium-related markers were not expressed in normal NKSE. 
These findings are in agreement with the observations made by Nagle et a\.u and 
Morgan et al.15 
After malignant transformation, the typical Cks of the oral epithelium were retained 
to a varying extent but their expression changed thoroughly. The changes were related 
to the degree of cellular differentiation, tumor cell morphology, and tumor growth 
pattern. They were mainly characterized by a decreased expression of the stratification 
markers Cks 4 and 13 and an increased expression of Cks 14,17, and 16. With increa-
sing tumor grade the enhanced expression of Cks 17 and 16 decreased. Generally these 
changes agree with the findings reported by Morgan et al.,16 Heyden et al.,17 Kannan 
et al. , '8 and Váida et al. " Although Cks 5 and 17 are considered to be basal cell 
markers, their expression largely differed from that of the other basal cell marker Ck 14. 
Vaidya et al.20 observed a similar expression of Ck 5 in SCCs of the buccal mucosa, 
which was ascribed to epitope masking. Ck 17 is considered as a basal marker of 
complex epithelia,21 but the absence of Ck 17 in the basal cells of normal NKSE of the 
oral cavity makes this assumption questionable at least for the oral NKSE. The present 
observations demonstrate that the expression of Ck 17 is similar to that of the 
hyperproliferation-associated Ck 16. This observation supports the assumption of de 
Jong et al.22 and Vennix et al.23 that Ck 17 might also be associated with hy-
perproliferation. 
In addition to the changes in the expression of Cks typical of oral epithelium, the 
simple epithelium-related Cks 7, 8, and 18 and vimentin became expressed during 
malignant transformation. They could not be detected in the normal oral epithelium and 
in benign oral lesions and might therefore be considered to be related to (pre)neoplasia. 
The highest expression levels were found in high-grade tumors, in the borders of small 
infiltrating tumor strands and in tumors with a basaloid phenotype. Frequently, Cks 8 and 
18 and vimentin were coexpressed. Expression of simple epithelium-related Cks as well 
as of vimentin has been described in SCCs from various sites of the body. 6 '9 '2A Araujo 
et al.25 and Imai at al.26 reported the expression of vimentin in high-grade SCCs of the 
oral cavity. In these studies, vimentin expression was observed in spindle cells and in the 
periphery of tumor strands. Marked expression of Cks 8 and 18 often coexpressed with 
vimentin at the tumor front of various SCCs has been shown by Schaafsma et al. 6 These 
authors suggested that this phenomenon might reflect a phenotype involved in invasive, 
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migrating, and proliferating activities of the tumor in these areas. 
In this context it is noteworthy that oral SCCs with a basaloid phenotype (BSCC) 
showed a strong expression of Cks 8 and 18 and of vimentin. BSCCs are now 
considered as a separate histological entity.27,28 These tumors, made up of small round 
cells with little cytoplasm and large nucleoli, are characterized by a more aggressive 
behavior than non-BSCCs. 
The present ¡mmunohistochemical observations on SCCs of the oral cavity reveal a 
striking similarity with the expression of Cks and of vimentin in laryngeal carcinomas, 
although the expression of vimentin was more pronounced in the oral SCCs. In addition, 
in contrast to lymph node metastases of oral SCCs, vimentin was not observed in the 
metastases of the laryngeal carcinomas studied. Whether this phenomenon is related to 
the different growth pattern of both SCCs cannot be determined. 
In summary, the present study indicates that changes in the Ck phenotype can 
contribute to the malignancy grading of lesions of the oral cavity. In particular, the 
expression of simple epithelium-related Cks 8 and 18 and of vimentin in SCCs growing 
in small infiltrating fields and tumors consisting of basaloid cells suggests a relationship 
with invasive properties and poor prognosis. 
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INCREASED EXPRESSION OF CYTOKERATINS 8, 18 AND 
VIMENTIN IN THE INVASION FRONT OF 
MUCOSAL SQUAMOUS CELL CARCINOMA 
ABSTRACT 
The immunohistochemical expression patterns of cytokeratms (Cks) 8 and 18 and 
vimentin were examined in frozen sections of 120 human mucosal squamous cell 
carcinomas (SCCs) with special emphasis on the topological distribution in the 
tumor This was done in order to evaluate in SCC a particular expression pattern 
observed recently by us in transitional cell carcinoma of the urinary tract and 
designated as an "interface phenomenon " This phenomenon implying maximum 
expression of Cks 8 and 18 at the tumor front, and to a lesser extent also in areas 
of intratumorous stroma contact, was also found in about 50% of the SCCs 
examined It was even found for vimentin, which contrasted with transitional cell 
carcinoma The percentages of occurrence of the phenomenon varied for the 
different sites of origin of the tumor Tumor grade did not influence the results These 
findings further support the idea that invasive carcinoma cells interacting with the 
stromal microenvironment display a characteristic intermediate filament phenotype 
that deviates from the pattern expected on the basis of their direction of differentia-
tion These changes might reflect phenotype involved in invasive, migrating, and 
proliferating activities 
INTRODUCTION 
Although the original "rules" of vimentin and cytokeratin (Ck) expression' are still 
helpful, new insights have shown the situation to be more complex. For example, Ck 7 
is, as a rule, expressed in many simple epithelia and remains predominantly restricted 
to adenocarcinomas.2 It is only sporadically and focally expressed in squamous cell 
carcinomas (SCCs).2,3 On the other hand, Cks 8 and 18, also considered as specific for 
simple epithelia in early studies,'*'5 are found variably in SCCs.3,4,6,7 A positive correlation 
between increased expression of Cks 8 and 18 and an increase in the histological grade 
of anaplasia has been reported. Only recently, a relationship between Cks 8 and 18 
expression and location of carcinoma cells at the tumor invasion front or in other areas 
of stroma interaction '9 has been reported. Increased expression of vimentin in 
carcinomas was found to be related to parameters of malignant potential such as grade, 
growth fraction, hormone independency, and survival rate.'0'''' Encouraged by these 
data, we have studied such topographical expression patterns in carcinomas, in 
particular those with expected low amounts of Cks 8 and 18, and vimentin, i.e., SCCs.4 
MATERIALS AND METHODS 
Tissues 
One hundred and twenty fresh tumor samples of SCCs from different mucosal sites 
were obtained after surgery (Tables 1 and 2). A small sample from the specimen was 
snap-frozen in liquid nitrogen and stored until further use. From the head and neck 
region we collected 80 samples of non-irradiated, SCC lesions (from 61 different 
patients) including 65 primary tumors and 15 samples from lymph node metastases. 
Forty SCC samples were taken from the vulva, oesophagus, and lung. Spindle cell 
carcinomas were not included in these series. 
Samples were preferentially taken from the transition zone between tumor and 
surrounding tissue. The pathology diagnosis was made on routinely processed tissue 
samples. The carcinomas were graded according to WHO criteria.15 
/mmunoh/s/ochemisfn/ 
The indirect immunoperoxidase technique was applied to approximately 5 /Jm 
parallel cryostat sections, essentially as described before.'6 The panel of monoclonal 
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Tumor ; 
number 
¡ite, grade, and 
of cases 
Floor of mouth 
Gr l 
Gr2 
Gr3 
Tongue 
Gr l 
Gr2 
Gr3 
Tonsil 
Gr l 
Gr2 
Gr3 
Larynx 
Grl 
Gr2 
Gr3 
Lung 
Gr l 
Gr2 
Gr3 
n = 3 
n= 7 
n= 4 
n = 5 
n= 10 
n-=3 
n = 4 
n - 5 
n = 2 
n= 10 
n = 8 
n = 19 
n - 9 
n = 10 
n = 8 
Oesophagus 
Gr2 
Gr3 
Vulva 
Gr l 
Gr2 
n= 3 
n = 3 
n = 2 
n = 5 
Extensive 
staining* 
-
-
-
-
4 
2 
-
1 
-
-
-
-
1 
-
-
-
-
-
-
Limited 
staining + 
2 
3 
3 
3 
4 
-
3 
2 
1 
2 
3 
6 
1 
3 
4 
3 
1 
1 
5 
Total no. of positive 
cases (percentage) 
8 (57%) 
13 (72%) 
7 (64%) 
11 (30%) 
9 (33%) 
4(66%) 
6(86%) 
'Extensive positivity: more than 75% of tumor cells were stained. 
+ Focal positivity: less than 25% of the tumor cells, especially those cells located in small tumor cell 
clusters and protrusion, were stained. 
Table 1. Vimentin staining patterns in mucosal squamous cell carcinomas 
antibodies consisted of the chain-specific anti-cytokeratin 8 antibodies CAM5.26'17'18 and 
M20,'6-18 the anti-cytokeratin 18 antibodies 2C8,16 RGE53,5 CK18-2,16 and RCK106;'6 
and the anti-vimentin antibody RV202.'6 The slides were assessed by one experienced 
pathologist. The degree of Ck staining was scored as - (negative), ± (limited staining, 
i.e., less than 50% of the cells were positive), or + (extensive staining, i.e., more than 
50% of the cells were positive). On some occasions, sporadic positivity was noted 
separately, representing less than 1 % of positive cells. Vimentin staining was divided into 
two groups: one showing extensive positivity (more than 75% of the carcinoma cells were 
positive) and the other showing focal positivity (less than 25% of the cells were positive). 
RESULTS 
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Express/on of vimentin 
In 58 (48%) samples, vimentin-positive carcinoma cells were found. Two types of 
vimentin staining pattern of the tumor cells could be observed (see Table 1). The first 
pattern consisted of randomly extensive staining of (large) areas of the carcinoma (Figs 
1A - D). The second pattern was formed by (small) positive clusters of basal and 
parabasal cells, located preferentially in extensions protruding from the tumor cell 
clusters (Figs IE - G). The number of vimentin-positive cases was approximately the 
same in samples containing the most peripheral part of a tumor as compared with 
samples containing centrally located portions. The smallest cell clusters that showed 
strong vimentin staining were most frequently found in the outer rim of the conglomerate. 
The number of vimentin-positive epithelial cells in the protrusions varied, ranging from 
Figure 1. Immunoperoxidase staining in frozen sections of mucosal SCCs. Extensive vimentin staining is shown 
in A and C, while in parallel sections (B stained with M20; D stained with CAM5.2) the carcinomatous area 
(in С and D, small arrows are placed inside a cluster of carcinoma cells) also shows expression of Ck 8. Note 
that in parallel sections С and D, adjacent squamous epithelium (large arrow) is negative for Ck 8 (CAM5.2) 
and vimentin. (Ε-G) Preferential vimentin expression in the tumor front (E; front on the left side, see small 
arrows) and tumour buds (F,G). Tumor origin: tongue (Α-D); tonsil (E); lung (F); vulva (G). 
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α few cells to many cells in most of the buddings The frequency of vimentin-positive 
cases differed between carcinomas from different sites of origin (Table 1) The 15 
metastases from the head and neck carcinomas showed the same vimentin expression 
levels as their primary lesions No relation was found between the presence of vimentin 
expression and the degree of keratinization or other parameters of tumor grade 
Expression of Cks 8 and 18 
Expression according to cell types - Both Cks 8 and 18 were frequently (in 90% of 
the cases) expressed in the SCCs (Table 2) Their distribution pattern was heterogeneous, 
while the number of positive cells varied considerably between different cases and 
between different regions within the same tumor Cks 8 and 18 were found to be 
preferentially expressed in the peripheral (basal) cells of the tumor cell clusters, often 
extending into the parabasal region In some cases, all the cells of a tumor cell cluster 
were found to be positive Occasionally a rim of Ck staining was found only on the 
stromal side of basal cells (Figs 2A - B) 
In sporadic cases (6 out of 120 samples), Cks 8 and 18 staining was found focally 
in the supra basal cell layers (Fig 2C) or only in the layers bordering comifying cells (Fig 
2D), while the other layers were predominantly negative 
Expression according to tumor area - Cks 8 and 18 expression was often found in 
the area of the tumor front with the surrounding tissue This phenomenon was observed 
in about half of the 74 samples, in which the outer rim of the tumor was present (see 
Table 3 and Figs 2E-G) The basal and parabasal cells at the tip of the protruding cell 
clusters often showed the highest levels of expression This phenomenon was observed 
in tumors of different grades and degrees of keratinization 
Oc gradients as detected by different antibodies - The two anti-cytokeratin 8 
antibodies CAM5 2 and M20 produced similar staining patterns, although the CAM5 2 
staining patterns were generally slightly stronger and/or more extensive than the patterns 
for M20 In eight head and neck carcinomas, however, a significantly lower staining 
level or even a negative results was seen with M20 (Fig 3), while CAM5 2 stained more 
extensively 
The four different anti-cytokeratin 18 mono-clonal antibodies also showed differences 
with respect to the proportion of positive tumor cells (Figs 2H - J and 3) 
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Tumor site, grade, 
number о f cases 
Floor of mouth 
gr l n^ 
g r 2 n = 
gr3 n = 
Tongue 
g r l n = 
gr2 n = 
gr3 n = 
Tonsil 
grl n = 
g r 2 n = 
g r 3 n = 
Larynx 
grl n = 
g r 2 n = 
gr3 n = 
Lung 
gr l n = 
g r 2 n = 
gr3 n = 
3 
7 
4 
5 
10 
3 
4 
5 
2 
10 
8 
19 
9 
10 
8 
Oesophagus 
g r 2 n = 
gr3 n = 
Vu/vo 
gr l n = 
gr2 n -
3 
3 
2 
5 
8* + 
1 
2 
1 
2 
2 
10 
ó 
7 
4 
1 
Extensive staining 
8 + 
18 + 
1 
4 
1 
1 
3 
1 
2 
8 ± 
18± 
1 
2 
1 
3 
1 
1 
8 ± 
18 + 
Limited staining 
8 ± 
18± 
1 
2 
1 
2 
3 
1 
1 
4 
1 
4 
4 
2 
1 
1 
2 
2 
1 
8-
18-
1 
1 
1 
1 
1 
1 
18± 
1 
1 
1 
2 
1 
1 
1 
1 
1 
1 
Negative 
1 
2 
1 
1 
2 
2 
2 
1 
'Cytokeratin number. Extensive staining and + indicate that more than 50% of the (basal and 
parabasal) cells were positive. Limited staining and ± indicate that less than 50% of the (basal and 
parabasal) cells were positive Negative and - indicate that no specifically stained cells were found. 
Table 2. Cks 8 and 18 levels as detected by antibodies CAM5 2 and RCK 106, respectively, in mucosal SCCs 
scored with respect to tumor grade, irrespective of tumor area 
Firstly, the antibodies RCK106 and CK18-2 stained similarly and most extensively, 
although RCK106 reacted slightly more extensively than CK18-2. Secondly, RGE53 
showed less extensive staining patterns and smaller numbers of positive cases compared 
with RCK106 and CK18-2. Finally, the least staining was observed with 2C8. As a result, 
the 2C8-positive areas were increasingly overlapped by RGE53-, CK18-2-, and 
RCKlOó-positive areas. Basically, taken together the results indicate that a so-called 
"gradient-pattern" exists for the extent of staining by the anti-cytokeratins 8 and 18 
antibodies.8,14 
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Figure 2. Immunoperoxidase staining in mucosal SCCs for Cks 8 and 18, employing different monoclonal 
antibodies. Note the linear staining on the stromal side of peripherally located carcinoma cells as shown in 
A and В with antibody CAM5.2. С shows a random staining pattern with M20, while in D only the cell layer 
directly beneath the keratinized cells is stained with CAM5.2. (Ε-G) Most staining is shown in the tumor front 
(on the left side of the figures) with antibodies CK 18-2, RCK 106, and M20, respectively. (Η-J) Gradient 
pattern for Ck 18 in a pulmonary squamous cell carcinoma displaying most staining with RCK 106 (H), slightly 
less staining with RGE53 (I), while in a detail of the same area as shown in h and I only weak staining is seen 
with 2C8 (J, arrows). Note the strong staining of residual alveolar cells in J. Origin of tumors: larynx (A,B,C,G); 
floor of mouth (D,E); tonsil (F); lung (H-J). 
related to each other. Overlap of the staining patterns was, however, not complete. 
Frequently the positive areas were distributed differently or their staining levels varied 
(Table 2). 
Tumor sta/ning levels according to site of origin - The expression levels of both Cks 
8 and 18 as well as vimentin varied between the tumors from different sites of origin 
(Table 1 and Fig. 3). Pulmonary SCCs showed a rather extensive Cks 8 and 1 8 staining 
reaction, while, for example, vulvar carcinomas showed low levels of Ck expression. In 
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Tumor site 
number ol 
ι, grade, and 
! cases 
Floor of moufh 
grl n-
g r 2 n = 
gr3 n = 
Tongue 
grl n = 
gr2 n = 
gr3 n = 
Tonsil 
gr l п ^ 
gr2 n -
gr3 n = 
Larynx 
grl n^ = 
gr2 n = 
gr3 n = 
Lung 
grl n ^ 
gr2 n -
gr3 n = 
3 
3 
3 
3 
7 
3 
1 
3 
1 
7 
5 
13 
4 
•5 
3 
Oesophagus 
gr2 n = 
gr3 η --
Vu/va 
gr l n = 
gr2 Π-
Total n = 
2 
3 
• 1 
2 
74 
Increased expression 
of Ck 8 and/or 1 θ in the 
lumor invasion front 
Simultaneous expression of 
vimentin and Ck 8 and/or 18 
in the tumor invasion front 
63% 
69% 
20% 
3 
2 36°/; 
4 
1 4 1 % 
3 
- 40% 
66% 
35 48% 14 of 35 
'Only those samples that actually contain a lumor margin (74 of the 1 20 samples) are scored 
Table 3. The numbers of cases showing Cks 8 and 1 8 expression in Ihe tumor invasion front (middle column) 
and with simultaneous vimenhn expression in the invasion fiont (right column)* 
this series, no consistent differences in the staining patterns between the primary tumor 
and metastasis were noticed. 
Although vimentin was also positive in these same types of budding tumor areas, no 
consistent topological correlation with Ck expression was seen (Table 3). 
DISCUSSION 
Although little is known about the function of the different types of intermediate 
filament, new perspectives have been opened up by as yet incompletely understood 
patterns of Ck subtype and vimentin expression in the course of neoplastic disease. ' 4' 
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1 2 3 4 5 6 
100% 
7 5 % -
5 0 % 
2 5 % 
0 % ' 
floor of mouth 
I D NEGATIVE 
УІ 
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tongue larynx 
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oesophagus 
Figure 3. Levels of Cks 8 and 18 expression in mucosal SCCs (Grade 1-3) of different sites of origin, as 
monitored by the six different monoclonal antibodies used. Extensive positivity: more than 50 % of the cells 
were stained. Limited positivity: less than 50 % of the cells were stained. Sporadic positivity: only very few (less 
than 1 %) cells were positive. Negative; no specific staining of tumour cells was seen. The six individual bars 
per tumor type represent the results of the six antibodies, i.e., 1 :CAM5.2; 2:M20; 3: RCK 106; 4: С 18-2; 5: 
RGE53; 6:2C8. 
Recently, we described the influence of the position of tumor cell clusters within 
transitional cell carcinoma on Cks 8 and 18 expression.8 In such tumors, increased Cks 
8 and 18 expression was found especially in the invasion front a n d , to a lesser degree, 
in areas of ¡ntratumorous stroma contact. In the present study, we examined SCCs of 
diverse sites of origin for this so-called "interface phenomenon." The normal squamous 
epithelium did not in general express Ck 8 or 18 when tested with our antibodies. SCCs 
were chosen because of their supposed low expression levels of Cks 8 and 18, in 
contrast to adenocarcinomas which normally show high levels of these intermediate 
filament protein subtypes.4 Although in our initial study8 vimentin did not exhibit the 
interface phenomenon in transitional cell carcinoma, we included this intermediate 
filament protein in the present study because of reported vimentin expression in 
SCC , 0 · 2 1 ' 2 2 
Simple Cks in SCCs 
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Our present panel of Ck subtype-specific antibodies indicated gradients of expression 
of these constituents, especially for Ck 18 in transitional cell carcinomas and SCCs 8 '6 
Such reaction patterns for Ck subtype antibodies have also been described by others and 
have been related to antigen quantity or the epitope masking phenomenon Bosch et 
a/2 3 demonstrated Cks 8 and 18 in basal cells of normal mucosal squamous epithelium, 
although in very low concentrations These authors related the presence of these Cks to 
the proliferative potential of the cells in these layers In their view, it was therefore 
understandable that Cks 8 and 18 were expressed in SCCs 
As expected, and in line with the results of others,6 7 we found that most of the SCCs 
examined expressed Cks 8 and 18, although in variable degrees In our study, the 
expression level was not found to be related to tumor grade, as reported by others 
However, in our view an additional important aspect was the topographical distribution 
of the cells expressing Cks 8 and 18 8 In the SCCs that we examined, these Cks were 
predominantly expressed in the peripherally located (basal) tumor cells The most likely 
area of detection is in the outer nm of the whole tumor, ι e , the invasion front, a 
phenomenon not observed for other Cks (unpublished observations) This interface 
phenomenon was not found at every tumor margin 
Similar observations of Cks 8 and 18 expression at the stroma-tumor interface have 
been reported for SCCs derived from the keratinizing squamous epithelium of the skin 9 
These findings showed that SCCs originating from normally keratinizing squamous 
epithelium might also express Cks 8 and 18, and that this phenomenon was not only 
restricted to SCCs derived from mucosal epithelia 
From Fig 3 it can be seen that expression of both Cks 8 and 18 occurs to a higher 
extent in SCCs that originate from simple epithelia through squamous metaplasia (for 
example, lung) than in those derived from pre-existing squamous epithelium The recent 
observations by Smedts et al3 in cervical SCC support this finding 
Expression of Cks 8 and 18 and vimentm in relation to proliferation 
Few reports on the relation between intermediate filament expression patterns and the 
biological behaviour of a tumor are available2 0 In this respect, recent publications on 
the presence of vimentm in breast carcinoma in relation to expression of the 
proliferation-associated marker Ki67, metastatic potential, and prognosis are 
important1 3 '4 Coexpression of vimentm and Cks in several other types of cancer has 
been reported to be correlated with a poor prognosis, but frequently this was only related 
98 CYTOKERATINS AND VIMENTIN IN THE HEAD AND NECK 
to tumor grade.11,12 
Although in this study maximum expression of Cks 8 and 18, as well as vimentin, was 
found in the proliferating front of SCCs, we were not satisfied with the hypothesis that the 
expression of these constituents was completely due to the supposed proliferative activity 
of the tumor cells in this region. A morphological argument against the proliferation 
hypothesis and in favour of a correlation between Cks 8 and 18 expression, on the one 
hand, and an interaction with the neighbouring cells, on the other hand, was the 
preferential presence of these proteins on the stromal side of the tumor cells (Figs 2A, 
2B, and similarly IG). Recent data on Ck 8 neoexpression in mouse skin SCCs and 
absence of Ck 8 in papillomas have been described as being important in relation to 
invasive growth.2'' We must keep in mind that at the stroma-tumor interface, and 
especially in the tumor front, several complex biological events take place. 
Environmental influence on Oc expression 
Data on all sorts of environmental influences on Ck expression must be taken into 
account when interpreting the Cks 8 and 18 expression patterns as described above.25,26 
Treatment of the squamous cancers by means of radiotherapy and/or chemotherapy 
was shown to influence intermediate filament expression patterns in these tumors. Fischer 
et al.27 correlated vimentin expression in head and neck cancers to previous non-surgical 
treatment. They found expression of vimentin in a lower percentage of cases compared 
with our study. This was remarkable, as in our study only untreated cases were included. 
This difference might be explained by the use of different antibody panels and other 
technical factors. 
Recent reports have shown an influence of underlying mesenchyme or basement 
membrane component on Ck expression in epithelial cells.27,28 Collagen VII, which 
constitutes the anchoring filaments of the basement membrane, was reported to be 
absent around simple epithelia which were Cks 8 and 18-positive, and to be present at 
the borderto stratified (squamous) epithelia,29 which are normally negative for Cks 8 and 
18. 3 This basement membrane constituent was also abundantly present in SCCs of 
different origins, but might be absent in the invasion front.29,30 It was therefore tempting 
to test the hypothesis of the coincidence of Cks 8 and 18 or vimentin-positive cell buds, 
on the one hand, and the absence of collagen VII around these structures, on the other 
hand. Our preliminary studies have so far not shown such a correlation (unpublished 
data). 
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Cks 8 and 18 are not always associated with vimentin 
In this study, we found colocalization of vimentin and Cks 8 and 18 in only a minority 
of cases. In most of the SCCs examined, these intermediate filament proteins showed 
apparently independent expression patterns. Coexpression of vimentin and Cks has been 
reported before in head and neck SCCs.10,22 Wallner et a/.21 have noted that vimentin 
and Ck are coexpressed mainly in the tumor invasion front. In these studies, however, 
broad-spectrum Ck antibodies, often recognizing several of the Ck subtypes, were used. 
In our study we concentrated deliberately on two Ck subtypes normally not present in 
squamous epithelium, i.e., Cks 8 and 18. Henzen-Logmans et a/.10 have described a 
relation in SCC between tumor grade and vimentin expression, while others have not 
found such a relationship.21,22 In our study, the small cell clusters positive for Cks 8 and 
18 or vimentin could also be found in well-differentiated carcinomas. 
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SUMMARY AND CONCLUSIONS 
This study was intended to provide greater insight into the biological behavior of 
head and neck squamous cell carcinomas (HNSCCs) on the basis of the expression 
patterns of the differentiation markers, cytokeratins (Cks) and vimentin. 
Firstly, a brief general introduction discusses the etiology, pathological classification 
and therapy of HNSCCs, as well as the significance of intermediate filament proteins 
(IFPs) as markers of differentiation. It also formulates the main aims of the study. 
Chapter 1 presents a critical analysis of the most relevant literature concerning Ck 
expression in normal and (pre)malignant head and neck epithelia. It pays special 
attention to the Cks, the IFPs of epithelia and their differentiation-related expression 
pattern. In addition, it discusses detection methods and possible technical and cell 
biological pitfalls in the study of IFPs, and points out the application of IFPs as markers 
for the differential diagnosis of head and neck tumors. 
Apparently only a limited fraction of the reported data add anything of significance 
to our knowledge of IFP expression in HNSCCs, mainly because of the use of 
heterogeneous tissue specimens and the application of only a small panel of antibodies. 
In addition, some of the applied methods are open to error. For example, due to fixation 
of the tissues, alterations can be induced in Ck epitopes. At times no mention is made 
of treatment protocols such as radiotherapy and chemotherapy, while control specimens 
often are lacking. In a small number of lesions tested with a broad panel of antibodies, 
several trends can be observed. The expression of the terminal differentiation markers 
decreases drastically in HNSCC and seems to correlate with the degree of differentiation. 
The simple epithelial markers become apparent in dysplasia and squamous cell 
carcinomas. 
Conclusion: a more complete immunohistochemical documentation of Ck patterns 
of well-defined (pre)malignant lesions is required together with a better correlation with 
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clinical parameters to prove the importance of Ck characterization to the biological 
behavior of HNSCCs. 
Chapter 2 describes the IFP expression patterns in normal epithelium and in various 
benign lesions of the vocal cords. In normal non-keratinizing stratified epithelium (NKSE) 
the basal cell markers Cks 5 and 14 were expressed in the basal cells. Ck 17 was also 
expressed in the (para) basal cells. The stratification markers Cks 4 and 13 showed a 
homogenous expression in the suprabasal cell layers. The keratinization marker Ck 10 
was only expressed in scattered cells of the suprabasal compartment. The 
hyperproliferation-associated Ck 6 was expressed homogeneously in the suprabasal 
cells, whereas Ck 16 showed a sparse to heterogeneous suprabasal expression in NKSE, 
depending on the size of the rete ridges. Ck 19 was expressed heterogeneously in the 
basal cells and focally in the suprabasal cells. The Ck profile of atrophic lesions did not 
significantly differ from that of normal NKSE, except in the keratinized areas. In 
(hyper)keratoticand hyperplastic lesions the Ck profiles show the most striking differences 
compared to normal NKSE. The lesions revealed extensive expression of the keratinizat-
ion marker, a decreased expression of the stratification markers and an increased 
expression of the basal cell Cks and the hyperproliferation-associated markers. A 
remarkable observation was the expression of simple epithelium-related Cks 8 and 18 
and of vimentin in the basal cells bordering fluid-filled blisters. This refers to specific 
properties of these cells related to the external environment. 
Chapter 3 describes the expression patterns of Cks and vimentin in squamous cell 
carcinoma (SCC) of the larynx and their lymph node metastases. Laryngeal SCCs 
revealed comprehensive shifts in the Ck profile. A distinct relationship was noted with 
tumor grading. The Ck profile of low-grade tumors showed a decrease of Cks 4 and 13 
and an increased expression of the basal cell Cks 14 and 17 and the hyperproliferation-
associated CK 16. Increasing dedifferentiation was generally accompanied by a futher 
loss of Cks 4 and 13. Remarkably, some grade 3-4 tumors showed an abundant 
expression of these Cks. The simple epithelium-related Cks 8 and 18 showed an 
increasing expression with advancing tumor grade with preference for the tumor margin, 
infiltrating tumor strands and in basaloid tumor cells. All tumors with lymph node 
metastases were positive for Cks 8 and 1 8. At the invasion front of the higher tumor 
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The Ck profiles of the lymph node metastases did not differ from those in the primary 
tumors and they did not show expression of vimentin. Vimentin expression in the tumors 
was not related to the presence of lymph node metastases. These observations show that 
changes in the Ck phenotype can be helpful in the diagnosis of lesions of the larynx and 
malignancy grading and may highlight other features of the tumor cells not established 
by conventional histology. The sites of marked expression of Cks 8,18 and vimentin 
suggest a possible relationship with enhanced cell mobility and invasive properties of 
tumor cells in these areas. Correlation with clinical behavior should show whether or not 
these profiles have a significant prognostic value. 
Chapter 4 describes the Ck and vimentin expression patterns in NKSE and in clinically 
benign lesions, including lichen planus and fibroma, of the oral cavity. The Ck profile 
of the normal NKSE did not significantly deviate from that of NKSE of the larynx, except 
for areas with rete ridges, where the Ck profile showed slight differences. In addition, 
sparse suprabasal expression of Ck 1 7 was observed. Merkel cells, situated in the (para) 
basal cell layers, showed expression of Cks 8 and 18. Hyperplasia or hyperkeratosis 
characterized the benign lesions. The alterations of Ck expression patterns of the lesions 
are mainly determined by keratinization and hyperplasia. The Ck profiles of hyperplastic 
lesions resemble that of normal NKSE except for suprabasal expression of the basal cell 
Ck 14. Hyperkeratotic lesions revealed a loss of the stratification markers Cks 4 and 13 
and an upregulation of the keratinization marker Ck 10, the hyperproliferation-
associated marker Ck 16 and the basal cell markers Cks 14 and 17. Expression of Ck 
19 and of vimentin was associated with the presence of a subepithelial inflammation. 
The conclusion is that leukoplakic lesions without dysplasia are characterized by varying 
shifts in the site-specific Cks. Expression of vimentin is associated with inflammation. 
Chapter 5 deals with the expression patterns of Cks and vimentin in SCCs of the mobile 
tongue, the floor of the mouth, and their lymph node metastases. 
Dysplastic areas next to SCCs generally show a similar Ck profile as compared to the 
primary tumor, although there may be quantitative differences. 
In SCCs the site-specific Cks were retained to a varying extent but their expression 
patterns changed. In addition simple epithelium-related Cks 7,8, 18 and vimentin, 
absent in NKSE, were expressed in the malignancies. The expression of these IFPs was 
106 CYTOKERATINS AND VIMENTIN IN THE HEAD AND NECK 
stratification markers Cks 4 and 13 accompanied increasing tumor grade. The 
expression of the simple cell markers Cks 8 and 18 and vimentin increased with 
increasing tumor grade and was most marked in the borders of small infiltrating tumor 
strands and in tumors with a basaloid phenotype. Lymph node metastases generally 
showed the same Ck and vimentin expression pattern as the primary tumor. No relation 
could be established between the expression of vimentin and the presence of lymph node 
metastases. These observations were strikingly similar to our findings in SCCs of the 
larynx, although the expression of vimentin was less pronounced in the laryngeal SCCs. 
In addition, vimentin expression was absent in lymph node metastases of the latter lesion. 
The conclusion for these lesions as well is that the expression of Cks 8, 18 and of 
vimentin is related to tumor features associated with a poor prognosis. 
Chapter 6 investigated the topographical distribution of Cks 8,18 and vimentin in 
HNSCCs and SCCs of the lung, esophagus and vulva. The majority of the lesions 
showed expression of Cks 8 and 18 in a variable degree. They were predominantly 
expressed at the outer rim of the tumor, the tumor invasion front and at the border of the 
tumor fields throughout the tumor. The vimentin expression pattern was to a lesser extent 
similar. This phenomenon was not related to tumor grade. We suggest that the 
carcinoma cells expression Cks 8, 18 and vimentin display an IFP phenotype reflecting 
invasive and migrating properties. 
CONCLUSIONS 
The following conclusions can be drawn from the observations made in this study: 
1. In the transition from NKSE to benign lesions of the vocal cords and the oral cavity, 
the site specific Cks are retained. The Ck profile of these lesions is related to the 
major changes of epithelial differentiation such as keratinization and hyperplasia. 
Neoexpression of the simple epithelium-related Cks 8 and 18 and vimentin can be 
induced by inflammation and in epithelial cells bordering blisters. 
2. In the transition from NKSE to SCCs the site-specific Cks are retained to a variable 
extent, but their regular expression pattern is severely disturbed. Furthermore, neo-
expression of simple epithelium-related Cks occurs. The changes are related to 
tumor grade, cell morphology and tumor growth pattern. 
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3. There is α striking similarity between the Ck expression patterns in SCCs of the larynx 
and of the oral cavity, but the expression of vimentin is more pronounced in SCCs 
of the oral cavity. 
4. In several HNSCCs the Cks 4,13 and 19showan unexpected expression pattern not 
in agreement with their differentiation. 
5. The expression of Cks 8 and 18 in SCCs was frequently associated with the 
expression of vimentin in infiltrating tumor strands and at the tumor front, and in 
SCCs with a basaloid cell phenotype 
6. The topographic distribution of Cks 8 and 18 and vimentin in SCCs suggests a 
correlation with tumor infiltration. 
7. Cks 8 and 18 might be considered as markers related to (pre)malignancy in NKSE 
of the head and neck region. 
8. The Ck profile of lymph node meia^tases of HNSCCs is generally similar to of the 
primary tumor, but in contrast to SCCs of the oral cavity, expression of vimentin in 
laryngeal SCCs was not found in their lymph-node metastases. 
9. The expression of vimentin in HNSCCs is not related to the presence of lymph node 
metastases. 

SAMENVATTING EN CONCLUSIES 
Tumoren in het hoofd en hals gebied kunnen in grote mate ingri|pen op het dageli|ks 
functioneren van de patient Spreken, slikken, ademhalen en niet in de laatste plaats het 
uiterli|k kunnen drastisch beïnvloed worden door de locoregionaire uitbreiding van de 
tumor en of door de behandeling van de tumor Beter inzicht in van het biologisch 
gedrag van hoofd-hals tumoren is noodzakeli|k om te voorkomen dat de patient een 
onnodig mutilerende behandeling ondergaat Helaas geven routine histopathologisch 
onderzoek en de TNM-classificatie onvoldoende inzicht in het klinisch gedrag van hoofd-
hals tumoren 
Sinds het midden van de |aren tachtig is er toegenomen belangstelling onstaan voor 
verschillende moleculaire markers ontstaan, die kunnen dienen als mogeli|ke 
voorspellers van het biologisch gedrag van tumoren, waaronder de differentiatie 
gerelateerde intermediaire filament proteïnen Deze eiwitten vormen een belangri|k deel 
van het cytoskelet en laten een celspecifieke expressie zien Het expressiepatroon van de 
cytokeratinen (Ckn), de intermediaire filament proteïnen van de epitheelcellen, is 
specifiek voor de verschillende typen epitheel Ckn komen in paren tot expressie Bi| een 
aantal pathologische epitheelafwi|kingen zoals, infectie, auto-immuun stoornissen en 
benigne en maligne nieuwvormingen, wordt een verandering in de bestaande Ckn 
expressie waargenomen Daarnaast kunnen nieuwe Ckn tot expressie komen, die met 
specifiek zi|n voor het originele epitheel Tevens kan naast de Ckn vimentine, een 
intermediair filament proteïne specifiek voor mesenchymale cellen, in een aantal laesies 
van het epitheel tot co-expressie komen 
In dit proefschrift wordt onderzocht of op basis van expressiepatronen van Ckn en 
vimentine aanvullende kennis verkregen kan worden van het biologisch gedrag van 
plaveiselcelcarcinomen (pcc's) afkomstig uit de mondholte en larynx 
In hoofdstuk 1 wordt een analyse gegeven van de relevante literatuur betreffende de 
Ckn expressie in normaal epitheel en (pre)maligne afwi|kingen in het hoofd-hals epitheel 
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De Ck expressiepatronen m het normale sli|mvlies zi|n specifiek voor de verschillende 
vormen van epitheliale differentiatie, zoals verhoorning, meerlagigheid en pseudo-
stratificatie De waargenomen Ck expressiepatronen bli|ken echter ook afhankeli|k te zi|n 
van de gebruikte immunologische technieken, bi|v gel elektroforese en immuunhistoche-
mie Tevens speelt de gevoeligheid en de specificiteit van de gebruikte monoclonale 
antihchamen een zeer grote rol bi| de kwaliteit van de immuunhistochemische 
bepalingen Een belangri|ke tekortkoming bi| vele gegevens is het niet alti|d melden van 
eventueel eerder ingestelde behandelingen Met name radiotherapie kan van invloed zi|n 
op het Ck expressiepatroon Het Ck expressiepatroon in pcc's vertoont geen relatie met 
de tumorlokalisatie in het hoofd-hals gebied Daarentegen worden in pcc's een aantal 
duideli|ke tendensen waargenomen in de Ckn expressie De expressie van de stratificatie 
markers (Ckn 4 , 13) neemt sterk af in hoofd-hals tumoren en is gerelateerd aan de 
differentiatiegraad De simpele epitheliale / klier cel markers (Ckn 7, 8, 18 en 19) 
komen vooral tot expressie m dysplastische laesies en pcc's O p grond van de 
literatuuranalyse kan geconcludeerd worden dat meer uitgebreide registratie van de Ckn 
expressie van onbehandelde goed omschreven maligne afwi|kingen nodig is Daarnaast 
is het raadzaam eveneens de klinische parameters te betrekken bi| deze registratie om 
zodoende een relatie te kunnen leggen tussen de Ck expressiepatronen en het klinisch 
gedrag van hoofd-hals tumoren 
De expressie van Ckn en vimentine in normaal stembandepitheel en in benigne 
stembandafwi|kingen wordt beschreven in hoofdstuk 2 De basale cel markers Ckn 5 en 
14 komen tot expressie in de basale cellen van met-verhoornend meerlagig stembande-
pitheel Ck 17 komt niet alleen basaal maar ook parabasaal tot expressie De 
keratinisatie marker Ck 10 komt slechts spaarzaam in de suprabasale cellen voor De 
stratificatie markers Ckn 4 en 13 en de hyperprohferatie-geassocieerde marker Ck 6 
worden gezien in alle suprabasale cellagen Ck 16, eveneens een hyperprohferatie-
geassocieerde marker komt, afhankeh|k van de grootte van de rete lasten, in een enkele 
suprabasale cel tot expressie Heterogene basale en focale expressie in de suprabasale 
cellen wordt waargenomen bi| Ck 19 Atrofische stembandlaesies laten, met uitzondering 
van de gekeratiniseerde gedeelten, een zelfde Ckn expressie patroon zien als het 
normale stembandepitheel Hyperkeratotische en hyperplastische laesies vertonen de 
grootste verschuivingen in het Ckn expressiepatroon De expressie van de keratinisatie 
marker, de basale cel markers en hyperprohferatie-geassocieerde markers is sterk 
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toegenomen, daarentegen is de expressie van de stratificatie markers afgenomen 
Opvallend is de expressie van de simpele epitheliale cel markers Ckn 8 en 1 8 en 
vimentine in de basale cellen, die grenzen aan subepithelial blaren Deze cellen hebben 
mogeli|k specifieke eigenschappen, die gerelateerd zi|n aan externe factoren 
In hoofdstuk 3 wordt de expressie van Ckn en vimentine in pcc's van de larynx en 
lymfekliermetastasen beschreven Er wordt een relatie gezien tussen de differentiatie-
graad van de tumor en de verschuivingen m het Ck expressiepatroon In de beter 
gedifferentieerde tumoren wordt een afname waargenomen van de expressie van de 
stratificatie markers Ckn 4 en 13, terwi|l de expressie van de basale cel markers Ckn 14 
en 17 en de hyperproliferatie-geassocieerde marker Ck 16 is toegenomen Bi| een 
toename van de dedifferentiate wordt een verdere afname gezien van Ckn 4 en 13 
expressie Opvallend is dat enkele slecht gedifferentieerde tumoren een sterke expressie 
van Ckn 4 en 13 laten zien De simpele epitheliale cel markers Ckn 8 en 18 en 
vimentine komen met name tot expressie in het tumorfront, in de infiltrerende tumorveld-
|es van de slechter gedifferentieerde pcc's en in pcc's bestaande uit basaloide cellen De 
Ckn expressie in lymfekliermetastasen is geli|k aan die van de primaire tumor De 
vimentine expressie is daarentegen afwezig in de halskliermetastasen De expressie van 
vimentine in de pcc's kan niet gerelateerd worden aan de aanwezigheid van lymfeklier-
metastasen in de hals De plaatsspecifieke expressie van Ckn 8 en 18 en vimentine in 
de randen van detumorveld|es en in het tumorfront suggereert een mogeli|ke relatie met 
een toegenomen mobiliteit en invasieve eigenschappen van de tumorcellen in deze 
gebieden Nadere verbanden met klinische parameters worden gelegd om hieraan een 
potentiële prognostisch waarde te kunnen toekennen 
Hoofdstuk 4 beschri|ft de Ckn en vimentine expressie in het niet-verhoornende 
meerlagig epitheel van de mondholte en in diverse benigne laesies, zoals liehen planus 
en fibromen Het Ckn expressiepatroon van het gezonde epitheel van de mondholte is, 
behalve in de gebieden met rete lasten, geli|k aan die van het normale larynxepitheel 
Er is een geringe suprabasale expressie van Ck 1 7 Merkel cellen bevinden zich in de 
parabasale cellagen en laten een expressie zien van Ckn 8 en 18 
De verschuivingen in de Ckn expressie bli|ken met name bepaald te worden door 
keratinisatie en hyperplasie In hyperplastische laesies wordt behalve een toegenomen 
Ck 14 expressie geen fundamentele wi|ziging gezien in het Ckn expressiepatroon 
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Hyperkeratotische laesies vertonen een afname van de stratificatie markers Ckn 4 en 13 
en een toename van de keratimsatie marker Ck 10, de hyperproliferatie-geassoaeerde 
marker Ck 16 en de basale cel markers Ckn 14 en 17 gezien In afwi|kingen met 
subepithelial ontsteking komt in de (para)basale cellaag Ck 19 en vimentine tot 
expressie 
Benigne niet-dysplastische mondholte laesies worden gekenmerkt worden door 
verschuivingen in de specifieke Ck expressiepatronen De expressie van vimentine is 
gerelateerd aan ontsteking in de subepithelial cellagen 
In hoofdstuk 5 wordt de expressie van de Ckn en vimentine beschreven m pcc's van 
de mobiele tong en de mondbodem en de lymfekliermetastasen in de hals Dysplastisch 
epitheel naast de tumor vertoont een Ckn expressie die vri|wel identiek is aan die van de 
tumor, maar de expressie is minder uitgesproken In de tumoren bh|ft de expressie van 
weefsel-specifieke Ckn bli|ft ten dele gehandhaafd Tevens komt in een aantal tumoren 
Ckn 7,8, 18 en vimentine tot expressie De expressie van Ckn 7,8, 18 en vimentine 
vertoont een correlatie met de differentiatiegraad, celmorfologie en groeipatroon van 
de onderzochte tumoren In matig tot slecht gedifferentieerde pcc's neemt de expressie 
van Ckn 4 en 13 sterk af In de slechter gedifferentieerde tumoren komen de simpele 
epitheliale cel markers, met name Ckn 8 en 18 en vimentine tot expressie Deze 
intermediaire filamenten komen met name tot expressie in de randen van de infiltrerende 
tumorveld|es en in pcc's met een basaloid fenotype Het Ck expressiepatroon van 
lymfekliermetastasen is vergeli|kbaar met dat van de primaire tumor Er wordt geen 
relatie aangetoond tussen de expressie van vimentine in de tumor en de aanwezigheid 
van lymfekliermetastasen De Ckn expressie in pcc's van de mondholte vertoont een 
opvallende geh|kenis met de expressiepatronen, die waargenomen zi|n in de pcc's van 
de larynx met uitzondering van een minder uitgesproken expressie van vimentine m larynx 
pcc's De expressie van Ckn 8 en 18 en vimentine is gerelateerd aan tumorkaraktenstie-
ken, die geassocieerd worden met een slechte prognose 
Speciale aandacht aan de expressie van Ckn 8 en 18 en vimentine in het tumorfront 
van hoofd-hals tumoren en pcc's uitgaande van de long, oesophagus en vulva wordt 
besteed in hoofdstuk 6 In meeste tumoren is een, in kwantiteit wisselende, expressie van 
Ckn 8 en 18 te zien in het tumorfront en aan de randen van de individuele tumorveld|es 
De vimentine expressie is geringer maar laat hetzelfde expressiepatroon zien Dit typische 
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expressiepatroon vertoont geen duideli|ke relatie met de differentiatiegraad De expressie 
van Ckn 8 en 18 en vimentine in de tumorcellen kan duiden op weefsel invasieve 
eigenschappen 
CONCLUSIES 
De volgende conclusies kunnen getrokken worden uit voorgaande bevindingen 
1 Bi| de transformatie van gezond met-verhoornend meerlagig epitheel naar benigne 
laesies van de stembanden en mondholte bli|ft de expressie van de weefsel-
specifieke Ckn gehandhaafd Expressie van Ckn 8 en 18 en vimentine in de laesies 
wordt met name gezien bi| ontsteking en in epitheelcellen, die grenzen aan 
subepithelial blaren 
2 Bi| de transformatie van gezond met-verhoornend meerlagig epitheel naar pees 
bli|ft de expressie van de weefsel-specifieke Ckn slechts ten dele gehandhaafd Er 
worden grote wi|zigmgen gezien in de expressie van de bestaande Ckn en simpele 
epitheliale cel Ckn en vimentine kunnen tot expressie komen Deze wi|zigingen zi|n 
gerelateerd aan differentiatiegraad, celmorfologie en groeipatroon van de tumoren 
3 De Ckn expressiepatronen in pee's van de mondholte en larynx zi|n fundamenteel 
met verschillend De expressie van simpele epitheliale cel markers en vimentine in 
pee's van de mondholte is geprononceerder 
4 Er wordt m verscheidende pee's van de mondholte en larynx een voor de differentia-
tiegraad onverwachte expressie van Ckn 4, 13 en 19 gezien 
5 In de infiltrerende tumorvelden en het tumorfront van pee's en pee's met een 
basaloid fenotype komen frequent Ckn 8 en 18 met vimentine tot co-expressie 
6 De plaatsspecifieke expressie van Ckn 8 en 18 en vimentine in pee's suggereert een 
correlatie met tumorinfiltratie 
7 Ckn 8 en 18 kunnen mogeli|k beschouwd worden als markers die gerelateerd zi|n 
aan (pre)maligne nieuwvorming 
8 De Ckn expressie in lymfekliermetastasen van pee's van de mondholte en larynx is 
vergeli|kbaar met die van de primaire tumor Vimentine expressie wordt, in 
tegenstelling tot in de lymfekliermetastasen van de pee's van de mondholte, niet 
waargenomen in de lymfekliermetastasen van de pee's van de larynx 
9 Er bestaat geen relatie tussen de expressie van vimentine in pee's van de mondholte 
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en larynx en de aanwezigheid van lymfekliermetastasen. 
APPENDIX 1 
OVERVIEW OF CYTOKERATINS AND THEIR EXPRESSION PAHERNS IN HEAD AND NECK EPITHELIA 
cyokerahn 
C k l O 
Ck4 
Ck 13 
Ck5 
Ck 14 
Ck 17 
Ck6 
Ck 16 
Ck7 
Ck8 
Ck 18 
C k l 9 
marker 
cornification 
stratification 
basal cell 
hyper-
proliferation-
assoaated 
simple 
epithelium-
related 
MAb 
RKSE 60 
6B10 
1C7, 2D7 
AE14 
RCK107, LL001, 
LL002 
E3 
KA12 
LL0O25 
RCK105 
M20, 2C8 
RCK106 
LP2K, RCK108 
tissue 
KSE 
NKSE 
NKSE 
PSE 
NKSE 
PSE 
KSE, NKSE, 
KSE, NKSE, 
KSE 
NKSE 
PSE 
KSE, NKSE, 
KSE 
NKSE 
PSE 
KSE, NKSE 
PSE 
KSE, NKSE 
PSE 
NKSE 
PSE 
PSE 
PSE 
PSE 
type of expression 
SB(hom) 
SB(sparse) 
SB(hom) 
B(sparse) 
SB (horn) 
SB(hom) 
В (sparse) 
SB (horn) 
В (hom) 
В (hom) 
В (het) 
В (sparse) 
В (hom) 
В + SB (hom) 
SB (het) 
SB (sparse) 
SB(hom) 
merkel cell 
SB (horn) 
merkel cell 
SB (horn) 
В (het), SB (sparse) 
В + SB (horn) 
horn - homogeneous staining pattern 
het - heterogeneous staining pattern 
sparse - sparse staining pattern 
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APPENDIX 2 
Cytokeratin expression in head and neck eptithelium: (A) NKSE without rete ridges (B) 
NKSE with rete ridges and (C) PSE. 
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APPENDIX 3 
TYPES OF EPITHELIUM IN THE HEAD AND NECK 
Oral Cavity 
- attached gingiva, hard palate KSE 
- other subsites NKSE 
Oropharynx 
- base of tongue 
- other subsites 
Nasopharynx 
Hypopharynx 
Larynx 
- epiglottis, valse voce 
- ventricle 
- true vocal cord 
- subglottic region 
зі cord 
NKSE, KSE (sparse] 
NKSE 
NKSE, PSE (sparse) 
NKSE 
NKSE, PSE (sparse] 
PSE, ISE 
NKSE 
PSE 
118 CYTOKERATINS AND VIMËNTIN IN THE HEAD AND NECK 
APPENDIX 4 
TYPES OF EPITHELIUM IN THE LARYNX 
Sagittal view of larynx and the different types of epithelium por subsite 
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STELLINGEN 
behorende bi| het proefschrift 
CYTOKERATINS AND VIMENTIN IN BENIGN LESIONS AND 
CARCINOMAS OF THE HEAD AND NECK 
De expressie van Cytokeratmen θ en 18 is gerelateerd aan infi ltrative groei in 
plaveiselcelcaranomen (Dit proefschrift) 
II 
In tegenstelling tot hetgeen in de literatuur wordt beweerd is Cytokeratine 19 geen marker voor 
premaligniteit in het hoofd-hals gebied 
(Lindberg K, Rheinwald JG Am J Pathol 1989,134 89-98, dit proefschrift) 
III 
De expressie van intermediaire filament proteïnen in plaveiselcelcaranomen van de mondholte en 
larynx zi|n over het algemeen vergeh|kbaar met uitzondering van vimentine (Dit proefschrift) 
IV 
De expressie van vimentine en Cytokeratmen 8 en 18 wordt in benigne epitheliale laesies beïnvloed 
door extra-epitheliale factoren (Dit proefschrift) 
V 
Gezien de hoge incidentie van het ongedifferentieerd nasopharynxcarcinoom in het Verre Oosten is 
screening voor het Epstein-Barr virus geboden Daarvoor is de PCR methode uitermate geschikt 
(Tune CE, Liavaag PG, Freeman JL et al J Natl Cancer Inst 1999,91 796-800) 
VI 
Bi f patiënten behandeld voor een hoofd-hals carcinoom is het raadzaam om gestandaardiseerde 
schnfteli|ke voorlichting aan te bieden 
(Boer de MF, Pruyn JFA, Borne van den В et al Head Neck 1995,1 7 503-515) 
VII 
Identificatie van de behandelaar met zi|n patiënten is ongewenst, empathie daarentegen is 
noodzakeli|k 
Vili 
Een palliatieve behandeling kan alleen gegeven worden door een arts die de betrekkeli|kheid van zijn 
/ haar handelen inziet 
IX 
De term otitis media wekt ten onrechte de indruk dat dit ontstekingsproces beperkt is tot het 
middenoor 
χ 
Het beroemde adagium " form ever follows function " is niet alleen van toepassing op de 
hedendaagse architectuur en vormgeving maar eveneens op de cosmetische rhinologie 
(Louis Henri Sullivan - architect, Boston, USA 1856-1924) 
XI 
Joint-clinics werken verslavend 
XII 
Door het feit dat alleen gepromoveerde clinici in aanmerking komen voor de bezoldigde functie van 
chef de (poli)clinique wordt de organisatorische kwaliteit van met-gepromoveerde clinici ontkend 
XIII 
Volgens de wet worden skates en skeelers beschouwd als speelgoed en degene die ermee speelt is 
een voetganger Met deze wetgeving rolt de overheid achter de feiten aan 
XIV 
Bi| de naamgeving van hun kinderen dienen ouders zich niet te laten leiden door de voornamen van 
popsterren, voetbalhelden of filmvedetten, maar door een eenduidige schn|fwi|ze en 
uitspreekbaarheid van de gekozen voornaam 
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